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The Properties of 
 Organofluorine Compounds 
 
Chapter 1 
 
 
“Fluorine leaves nobody indifferent; it inflames emotions 
be that affections or aversions. As a substituent, it is rarely 
boring, always good for a surprise, but often completely 
unpredictable.” 
 
 
 
-M. Schlosser1 
 	  	  	  	  	  	  
	   2 
Elemental fluorine is the thirteenth most abundant element in the earthʼs crust;2 
however, organofluorine compounds are essentially absent in nature.3 The reason for 
the scarcity of natural occurring fluorinated organic molecules is three-fold. Firstly, the 
most common fluoride, mineral fluorite (CaF2), has limited solubility in water.4 The 
concentration of fluoride in seawater is 1.3 ppm compared to 19,000 ppm of chloride.3 
Secondly, fluoride is easily solvated in aqueous media rendering it a poor nucleophile 
for displacement reactions.3 Lastly, the haloperoxidase reaction that is responsible for 
forming other organo-halides cannot incorporate fluorine into organic molecules.3 This is 
a result of a higher redox potential for the oxidation of fluorine as compared to the 
potential for the reduction of peroxide.3 
Due to their chemical and biological properties, the demand for fluorinated 
molecules as pharmaceuticals and agro-chemicals has boomed since the late 1950ʼs.5  
Today, about 25% of pharmaceutical drugs on the market consist of at least one fluorine 
atom, driving the development for new chemical syntheses and methodologies for these 
organic molecules.6 Discussed below are the advantageous properties of fluorinated 
compounds. 
Chemical and Molecular Properties: 
Organofluorine compounds possess multiple properties beneficial for 
pharmaceutical drug design. These include electronic effects, conformational changes, 
and their lipophilic nature. Fluorine is the most electronegative of all atoms. Therefore, 
the exchange of hydrogen for fluorine alters the electronic properties of a molecule 
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significantly. As a bioisostere, fluorine can mimic the electronic properties of certain 
other functional groups, such as an alcohol without producing an encumbering steric 
effect.  The C-F bond has a Van der Waals radius of 1.47 Å, when compared to the 1.20 
Å radius of a C-H bond.6 If steric bulk is desired, a trifluoromethyl group may be used. 
This represents the size of an ethyl group while maintaining its electron withdrawing 
nature.7 
Fluorine not only alters the electronics of a molecule, it can also influence 
conformation. The electronegativity and lone pairs of fluorine may result in 
conformational changes of a fluorinated analogue.7 This is exemplified in Figure 1.1 
between methoxyphenyl and trifluoromethoxyphenyl groups. The methoxy group is 
arranged planar to the phenyl ring. Here the oxygen is sp2 hybridized. Its p-orbitals are 
aligned with the π-bonds of the aryl ring, allowing for conjugation. Replacing the 
methoxy with a trifluoromethoxy group creates an anti-periplanar arrangement.7 Electron 
density is shifted from the aryl ring to the C-F bond creating an sp3-hybridized oxygen. 
Its lone pairs are pulled away from the aryl ring eliminating planarity.7 The difference in 
methoxybenzene and trifluoromethoxybenzene conformations have strategically been 
used in inhibitors of cholesteryl ester transfer proteins, which are linked to coronary 
artery disease. A tetrafluoroethyl compound had an 8-fold increase in potency for the 
target protein due to the loss of planarity when examined against its ethoxy 
counterpart.8 
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 Hydrogen bonds with fluorine 
may also effect the conformation of a 
molecule.  This is a weak interaction 
when compared to hydrogen bonds 
with oxygen or nitrogen. The carbon-
fluorine bond is strong and therefore 
exhibits low polarizability. This is responsible for the weakening effect of hydrogen-
fluorine bonds.6 Figure 1.2 illustrates conformational changes with F-H interactions 
between regioisomers of 2- and 6-fluoronorepinephrine. Compound 1 partakes in 
hydrogen bonding allowing for a conformation in which it is an α-adrenergic agonist, 
whereas the isomer 2 hydrogen bonds in a way to be a β-adrenergic agonist.9 
During drug design, medicinal chemists must take into account how the molecule 
will get through biological barriers to get to its target. The compound must be polar 
Figure 1.2: Effects of Hydrogen Bonding 
 
Figure 1.1: Trifluoromethoxyphenyl Group (Left) vs. Methoxyphenyl Group (Right) 
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enough to exhibit solubility in water, yet 
lipophilic enough to pass through cell 
membranes without getting trapped in 
the bilayer. As a general trend 
fluorination increases lipophilicity when 
compared to its hydrogen 
counterpart. 10  Exceptions are with 
monofluorinated or trifluoromethylated saturated alkyl systems.10 Overlap occurs 
between the 2s or 2p orbitals of the fluorine and the orbitals of the neighboring carbon, 
resulting in a strong, non-polarizable C-F bond. Consequently, lipophilic character is 
increased.6 One calculation used to measure the lipophilic nature of a molecule is logP 
or log([soluteoctanol]/([solutewater]). This partition coefficient measures the likeliness of a 
molecule to exist in an organic solvent (octanol) over water.11 A higher logP correlates 
to a greater lipophilic nature of the molecule. This was exploited while studying a series 
of amide compounds for the treatment of asthma (3). Figure 1.3 shows a range of the 
substrates screened. In order for the compounds to be delivered to the target a greater 
lipophilic moiety was needed. Lengthening the alkyl chain increased lipophilicity but 
potency suffered. Insertion of fluorine into the series not only increased the logP, it also 
had a ten-fold favor in binding affinity shown in the in vivo studies.12 
 
 
Figure 1.3: Fluorine and Lipophilicity5 
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Effects of Fluorine in Medicinal Chemistry: 
Understanding key transformations and metabolic processes in the body is an 
important factor to drug design. The presence of a fluorine atom in a molecule can stop 
metabolic processes and change the reactivity.13 As such, the orthogonal differences 
between a fluorine and a hydrogen atom have been exploited for biological activity.13 
One of the major differences between fluorine and hydrogen atoms is the ability 
to form a cation. The production of F+ is impossible due to the highly electronegative 
nature of fluorine. Contrastingly, many biological and metabolic processes produce the 
H+ ion through heterolytic cleavage.13 The exchange of fluorine for hydrogen is exploited 
in drug development to alter biological activity. This technique is exemplified through the 
design of the anti-cancer agent 5-fluorouracil (8). Figure 1.4 illustrates the mechanistic 
action of this mechanism-based inhibitor. Fluorine in the 5-position halts the synthesis of 
thymidylate (7), a compound involved in cancer development. Biologically, thymidylate 
is synthesized through a complex with substrate (4), enzyme, and the methylene 
tetrahydrofolic acid cofactor (CH2FAH4).14 A Michael-addition from a cysteine residue of 
the enzyme onto the substrate, followed by subsequent attack onto the methylene 
tetrahydrofolic acid forms intermediate (5).14 A key transformation towards thymidylate 
production is through an abstraction of a proton followed by β-elimination of 
tetrahydrofolic acid. 5-fluorouracil (8) was designed to mimic the substrate. However, a 
fluorine in the 5 position blocks the beta-elimination. The F+ cation is not formed 
resulting in a trapped and inactive enzyme-substrate complex (9).14 
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Although fluorine will not form a cation, the anion is easily produced. Elimination 
reactions of the fluoride ion have been exploited in medicinal development. Eflornithine 
(10), a drug used in the treatment of African sleeping sickness was designed as an 
irreversible mechanism based inhibitor. This mechanism is classified as a pyridoxal 
phosphate (PLP) dependent enzyme-catalyzed reaction.13 Generally, the PLP 
complexes to an enzyme through a Schiff-base linkage. This complex can then undergo 
tautomerization releasing the enzyme to continue its function. However, as Figure 1.5 
illustrates, fluorine was incorporated in Eflornithine (10) to form an irreversible substrate-
enzyme complex. Elimination of a fluorine results in compound 13 prone to nucleophilic 
attack. The nucleophilic enzyme irreversibly binds to the substrate rendering it inactive 
(14).   
 
 
Figure 1.4: Thymidylate Synthase Inhibition 
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Not only are irreversible substrate-enzyme complexes formed through elimination 
pathways, they can also form through nucleophilic displacements. Figure 1.5 illustrates 
compound 16 irreversibly bound to the cysteine (15) of tubulin. This process releases H-
F to form 17, which was found to be responsible for anti-cancer activity. 
 
 
 
	  
Figure 1.5: Fluoride-based Mechanisms 
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Another concern of the 
medicinal chemist is metabolic 
stability. A drug must have a long 
enough half-life in the body to perform 
its desired action. However, harsh 
environments and metabolizing 
agents/mechanisms within the body 
may increase the clearance time 
resulting in decreased drug efficiency.  
When a compound is transported 
through the stomach it is subjected to extreme acidic conditions. If the compound has 
an acid labile group it may become protonated, and potentially, deactivate through 
rearrangements or side reactions.12 A fluorine in the β-position of such group redirects 
the electron density back into the system, creating a weaker nucleophile. As contrasts to 
prostacyclins 18, prostacyclins 19 and 20 are stabilized by β-fluorination to remain 
active even within the stomach (Figure 1.6).15  
Fluorine may be utilized to block the oxidative activity of the cytochrome P450 
enzyme class. An example of this strategy is shown with the cholesterol inhibitor, 
Ezetimib (Figure 1.7, compound 22). Introductory studies in rats suggested that 
disfavored metabolic reactions were occurring. Oxidation and de-methylation were two 
transformations that occurred to the precursor 21. Fluorination of 21 not only blocked 
Figure 1.6: Fluorination and Stability15 
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these metabolic processes, potency was also favored. Ezetimib was found to have a 40-
fold increase in potency compared to its hydrogen-containing analog.16 
 
 
 
 
 
 
Summary: 
In summary, utilization of fluorine in drug design is of great importance. The 
addition of a fluorine into potential pharmacophores may increase lipophilicity, hinder 
unwanted metabolic eliminations, alter conformation, as well as change reactivity. One 
complication in this design is the scarcity of organofluorines in nature. Therefore there is 
a high demand for new synthetic methodologies of fluorinated intermediates and 
compounds.                    
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Fluorinated Organic Molecules  
 
 
Chapter 2 
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The high demands to incorporate fluorine into drug design have sparked interest 
for new synthetic methods. Currently, fluorine may be introduced to molecules through 
electrophilic and nucleophilic reagents. Although an exhaustive list of these reagents will 
not be given, the most important developments in the synthesis of organofluorines will 
be highlighted.  
Electrophilic Fluorination: 
The ideal process for electrophilic fluorination is through the attack of a 
nucleophilic site onto an “electron poor” or “F+” species. However, the production of a 
lone “F+” is not achievable due to its instability. Therefore, fluorinating agents are 
strategically developed to mimic an electron-poor fluorine. Initially, elemental fluorine 
was the only source for this type of transformation. Liberation of the fluoride ion is the 
driving force for a nucleophilic attack onto F2. This produces the [(He)2s22p6] 
configuration to completely fill its valence shell.1 Utilizing F2 for electrophilic fluorination 
leads to complications in handling. Elemental fluorine is highly reactive, toxic, potentially 
explosive, and poorly selective. It is possible to hinder the reactivity through the dilution 
of F2 with inert gases such as nitrogen or argon. However, safer reagents, with a greater 
tolerance of substrate scope are desired. As a result, much attention has been placed 
on designing alternative electrophilic fluorinating agents. 1 
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Efforts to find new 
electrophilic fluorine sources 
began with nucleophilic 
displacement reactions as 
exemplified by F2. 
Fluoroxytrifluoromethane 
(CF3OF) responsible for the transformation from 23 to 24, and acetyl hypofluorite 
(AcOF) exemplified by reaction 25 to 26, are two examples of these reagents as shown 
in Scheme 2.1. Fluorination of steroids, olefins, enolates, and certain carboxylic acid 
derivatives have been reported with these compounds. 2,3,4,5   
Although organofluoroxy reagents were developed as 
alternatives to elemental fluorine they are also highly reactive 
species and can be difficult to handle. One major contribution to the 
field of electrophilic fluorination was the emergence of reagents 
bearing an N-F bond, which are less reactive and used with ease.1 Reactivity is 
decreased due to a lower electronegativity of nitrogen resulting in a stronger N-F bond.  
Many N-F derivatives have been developed as an electrophilic source; of the most 
popular is the commercially available Selectfluor (27).6 This versatile reagent is involved 
in the fluorination of aryl groups, steroids, organometallics, and nucleosides.1 Selectfluor 
and its N-fluoroquinuclidine derivatives electrophilic strength may be adjusted by 
altering groups on the non-fluorinated nitrogen. (CH3 , C8H7 < CH2Cl < CF3CH2). Other 
N-F fluorinating sources include N-fluoropyridinium salts (28), N-fluoro-N-
Figure 2.1: 
Selectfluor 
N
N
F
CH2Cl
Selectfluor
27 
Scheme 2.1: Organofluoroxy Reagents 
e 
AcO
R
CF3OF
O
R
F
O
1. LDA
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O
F
25 26 
23 24 
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alkylsulfonamides (29), perfluoroalkylsulfonamides (30), and N-
fluorobenzenesulfonimide (31) (Figure 2.1.2).7,8,9,10 
 
Nucleophilic Fluorination: 
 Nucleophilic fluorination reagents have been widely developed.1 Solvent effects 
are extremely important for their success.1 Protic solvents should be avoided, as the 
fluoride ion is easily solvated. In aprotic solvents, tight ion pairing must be overcome 
before the reactivity of the nucleophilic fluoride is advantageous.1 This can be 
accomplished with large, steric cations such as tetrabutylammonium 
fluoride (TBAF) (Figure 2.3, 32). The bulky steric groups, as well as 
a delocalizing effect by the alkyl chains help to reduce counter ion 
interactions.1  
 The simplest reagent to deliver a fluoride ion is hydrofluoric 
acid. In practicality, HF is a dangerous and corrosive material, which 
should be handled carefully. However, the reactivity may be 
suppressed through the dilution of H-F with amines. An example is  
compound 33 termed Olahʼs reagent (pyridinium poly(hydrogen 
Figure 2.3: TBAF 
Figure 2.4: Olahʼs 
Reagent 
Figure 2.2: Electrophilic Fluorination Reagents 
N
F
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fluoride)).11 These mixtures slightly weaken the nucleophilicity of the fluoride and more 
activated substrates are needed to achieve fluorination.1 
Another approach towards nucleophilic 
fluorination is combining the fluoride ion with a 
soft Lewis base. These may be different 
transition metals such as Pd, Sn, or Hg. Also non-transition metals have been used 
such as S-F.1 One of the most popular reagents is diethylaminosulfur trifluoride (34) 
(DAST)12 and its dimethoxy counterpart Deoxo-fluor (35)13  (Figure 2.5). The latter 
reagent has a greater thermal stability and may be used as safe alternative to DAST as 
it is reported to detonate above 90 oC.1 
Fluorodeoxygenation of alcohols (36 to 37)14 
and the addition of difluoromethylene to 
carbonyls (38 to 39)13 are examples of 
fluorination reactions involving these reagents 
(Scheme 2.2).  
Summary: 
In summary, without the emergence of electrophilic and nucleophilic fluorine 
reagents, new synthetic methods for fluorinated organic molecules would be scarce. 
These contributions are essential for the discovery of new chemical entities. Therefore, 
much attention is placed on using these and other reagents for the production of mono, 
di, and tri-fluorinated molecules. 
Figure 2.5: Nucleophilic Reagents 
N
SF3
N
SF3
OMeMeO
DAST Deoxo-fluor
34 35 
Scheme 2.2: Examples of Nucleophilic Fluorination 
R
OH
R
F
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 The unique and advantageous properties of fluorinated compounds have driven 
the development for new reactions. Although a large number of organofluorine 
compounds have been prepared, remarkably little effort has been focused on aryl 
fluorides.  The three conventional methods for preparing aryl fluorides have drawbacks 
of harsh conditions and low substrate scope. Therefore, new synthetic routes to these 
compounds are desired. 
 A common approach to fluoroarenes is the Balz-Schiemann reaction developed 
in 1927.1 Aniline precursors (40) are converted to the corresponding fluoride (41) in the 
presence of tetrafluoroboric acid and sodium nitrite (Scheme 3.1). The reaction occurs 
through a diazo intermediate, which presents potential hazards. The substrate scope is 
limited as a result of the acidic reagent needed. The 
risk of explosion and toxic chemicals used create a 
liability for industrial application, and is therefore 
discouraged.  
  Another pathway for aryl fluorination is 
through nucleophilic aromatic substitution (SNAr) 
(Scheme 3.2). 2   The method involves direct 
formation of the fluoroarene (43) from aryl chlorides (42) or nitroarenes in the presence 
of a fluoride salt. One caveat is the necessity of an electron-withdrawing group on the 
arene. This deactivates the ring and increases the susceptibility for nucleophilic attack. 
Even with these substituents, temperatures as high as 450 oC have been needed.3 
Therefore, only a restricted amount of substrates are tolerated.  
Scheme 3.1: Balz-Schiemann Reaction 
R
NH2 HBF4, NaNO2
R
F
40 41 
42 43 
Scheme 3.2: SNAr 
EWG
Cl KF,  
up to 450 oC
EWG
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Lastly, aryl fluorides can be prepared using transition metal complexes. 
Nucleophilic and electrophilic fluorination sources have been used for these processes.  
Palladium-catalyzed transformations of aryl triflates to 41 have been reported with 
cesium fluoride.4 High reaction yields are limited to substrates with electron-withdrawing 
substituents. Electrophilic fluorination of aryl rings is also synthesized via transition 
metal catalysis. Typically an aryl stannane,5 silane6 or boronic acid7 is converted with 
palladium or silver and an electrophilic fluorine source. Although a wide range of 
substrates can be used, metal complexes such as 
44 are usually synthesized from aryl halides. 
Therefore, a direct approach of aryl halides to the 
corresponding fluoroarene (41) is widely desired.	   
Our Attempts Towards Aryl Fluorination: 
We became interested in halide exchange (halex) reactions due to the demand 
for a safe and general method to aryl fluorides. Many copper and nickel-mediated 
processes have been published for the exchange of iodides, bromides and chlorides.8 
However, the lack of literature precedent deems fluorination via a halex reaction a 
challenging task. In theory the reactions should favor the fluorinated product due to a 
strong C-F bond. Yet, the highly electronegative character of fluorine impedes product 
formation. The reaction proceeds with oxidative addition of the metal source into the aryl 
halide, resulting in intermediate 46 as shown in Scheme 3.4.9  The metal-fluorine bond 
of 46 is strong and difficult to break. For halex reactions with bromine and chlorine 
reagents, a stronger aryl-halide bond of the bromide or chloride drives the reductive 
R
M [Ag] or [Pd],
F+
R
F
M = B(OH)2, SnR3, SiX3
Scheme 3.3: Metal Catalyzed Approach 
44 41 
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elimination towards the production of 47 and M-I. Yet, in fluorination attempts the M-F 
complex of is too strong for reductive elimination to occur.  Therefore the M-F is 
eliminated, and starting material 45 is observed.9 
 
It was proposed that high heat 
associated with microwave technology 
may help facilitate halex reactions 
towards fluorination. The advantage of 
these microwave units is the ability to 
reach high temperatures in a controlled fashion. A pressure locking mechanism allows 
up to 300 psi of autogenic pressure within the vessel without failure. Previously, 
Leadbeater and Arvela reported nickel-mediated halide exchange protocols using 
microwave heating.10 Aryl iodides, bromides, and chlorides were all used as starting 
materials in conjunction with nickel (II) halide salts. A generic representation of 
exchange from 47 to 48 is depicted in Scheme 3.5. Substrates with electron-
withdrawing and donating substituents in the ortho and para positions were successful 
Scheme 3.4: Halex Reaction 
I
R
M
R
IM X X
R
X
Oxidative addition Reductive elimination
when X = F
when X = Br, Cl
Reductive elimination
I
R
M-I
M-F
45 46 47 
45 
Scheme 3.5: Microwave Promoted Halex 
X
R
MW, NiY2
DMF, 5 min, 170 oC
Y
R
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for the halide exchange. One disadvantage reported was the inability to produce aryl 
iodides from aryl bromide starting materials.10 Fluorination was not reported.	   
Halogen Exchange with Cu (II) Salts: 
The developed method for halogen exchange reactions using microwave heating 
and Ni (II) salts drove interest towards the utilization of Cu (II) salts. Our goal was to 
attempt the reaction with CuF2 to produce various aryl fluorides. In order to begin our 
investigation, we first desired to optimize a method for the halide exchange of aryl 
iodides to bromides. Aryl iodides are the most reactive starting materials in halex 
reactions. The C-I bond is relatively weak and is likely to undergo oxidative addition. If 
the halex transformation from aryl iodides were unsuccessful, most likely the other 
reactions would be as well. We chose 4-iodoanisole (49) as a test substrate due to the 
electron donating nature of the substituent. Initial attempts focused on using a 
stoichiometric amount of CuBr2 as both the bromine source and metal mediator of the 
reaction. Once complete, an ether extraction and water wash allowed for the isolation of 
the crude product. We monitored product yield via 1H NMR, with an internal standard 
1,2,4,5-tetramethylbenzene. This allows for quick analysis of results without performing 
further purification.  
Initial reaction screenings were successful in polar solvents such as n-methyl 
pyrrolidone and acetonitrile; which were chosen due to the greater solubility of the 
copper salts when compared to non-polar solvents. Observed conversions were 80% 
(Table 3.1, entry 1) in NMP, and near quantitative with acetonitrile (Table 3.1, entry 2).  
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We found that slightly longer reaction times were needed than the 5 minutes of the 
nickel mediated protocol.10 Starting material 4-iodoanisole was converted to 50 in 15 
minutes at 170 oC with CuBr2. The highest NMR yield observed was 70% (Table 3.1, 
entry 2).   
Subsequent trials were performed with a catalytic amount of CuBr2 and external 
bromide source (NaBr). This allows for a cheaper and greener reaction. Unfortunately, 
low conversions were observed with acetonitrile (Table 3.1, entry 3). We then focused 
on water as solvent with a phase transfer agent. This increases the solubility of the 
sodium bromide, which we hypothesized would increase the catalytic reaction 
conversion. Phase transfer agents polyethylene glycol and tetrabutylammonium 
bromide resulted in minimal conversions of 14% and 8% respectively (Table 3.1, entries 
4-5). The highest conversion observed was with ethylenediamine of 64%, but the 
resulting 14% recovery of the brominated product was not an acceptable yield. A longer 
reaction time of 30 minutes and a higher temperature of 180 oC was needed for this 
higher conversion (Table 3.1, entry 6). 
 
 
	   24 
 
 
 
 
 
 
 
 
 
With optimized halex 
conditions in hand for preparing 4-
bromoanisole, we next turned our 
attention towards the fluorination of 
49. The reaction was repeated with 
stoichiometric CuF2, in acetonitrile 
at 170 oC for 15 minutes. Product 51 was not observed. Thinking that the lower solubility 
of CuF2 could be a limitation to the halide exchange we then screened other polar 
solvents such as acetonitrile/water, DMA, DMA/water, and methanol. Again no reaction 
was observed.  
49 50 
Scheme 3.6: Halogen Exchange Trials 
70%
I CuBr2, solvent
MW 170 oC, 15 min
MeO
Br
MeO
I CuF2, solvent
MW 170 oC, 15 min
MeO
F
MeOx
49 
49 
50 
51 
Entry Cu Source 
Br 
Source Solvent Time Temp. Result 
 
1 
 
1.1 equiv. 
CuBr2 CuBr2 NMP 30 min 170 
oC 80% conversion, 39% recovered 
 
2 
 
1.1 equiv. 
CuBr2 
CuBr2 MeCN 15 min 170 oC 100% conversion, 70% recovered 
 
3 
 
0.1 equiv. 
CuBr2 NaBr MeCN 15 min 170 
oC 23% conversion, 21% recovered 
 
4 
 
0.1 equiv. 
CuBr2 NaBr H2O/PEG 15 min 170 
oC 14% conversion, 3% recovered 
5 0.1 equiv. CuBr2 NaBr H2O/TBAB 15 min 170 
oC 8% conversion, N/A recovery 
       
6 0.2 equiv. CuBr2 NaBr H2O/EDA 30 min 180 
oC 64% conversion, 14% recovery ! Table 3.1 Optimized Bromination 
I Cu2+, solvent
MW
MeO
Br
MeO
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One disadvantage to microwave reactors is that moderately polar reagents or 
solvents are needed for advantageous heating. Non-polar solvents with low dielectric 
constants are not the most suitable solvents for microwave-assisted reactions.11 Ionic 
liquids have been used in microwave reactors as heating aids. These are made up of 
organic cations and various anions. Therefore, we attempted the halex reaction in 
various 1-butyl-3-methylimidazolium [BMIM] ionic liquids. [BMIM]+ Br-, [BMIM]+ I-, and 
[BMIM]+ PF6- were screened and each time the reaction was unsuccessful. 
Consequently, we decided to move to alternative projects.  
The goal for our halide exchange attempts was to develop a facile method 
compatible with all halides, especially fluorine.  Efforts in ligand and catalysis design 
were not the focus of these attempts. However, it is important to note that since our 
initial trials the Hartwig group published a method for aryl fluorination from aryl iodides. 
The metal source and ligands were key for a successful transformation. This method 
focuses on the use of Cu1+ and nitrile ligands as 
key components for the reaction. Scheme 3.7 
summarizes this work, which allows for the 
reaction of electron-rich, neutral, and poor aryl 
iodides as acceptable starting materials.9  
 
  
 
R
I (t-BuCN)2CuOTf,
AgF
DMF, 140 oC, 22 h R
F
16 examples, 40-96%
45 41 
Scheme 3.7: Hartwig Developed Halex9 
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Summary: 
There is an ongoing interest for the halide exchange reactions of aryl halides to 
the corresponding fluoride. We focused on halex reactions using microwave reactors 
towards copper mediated fluorination. Although initial halex reactions of 4-iodoanisole to 
4-bromoanisole were successful, this method was not comparable to fluorinations. Our 
efforts were then focused towards other projects.  
 
 
 
 
 
 
 
 
 
 
 
	   27 
	  
References: 
 
1. Balz, G.;  Schiemann, G. Chem. Ber., 1927, 60,1186.  
 
2. Finkelstein, H. Ber. Dtsch. Chem. Ges., 1910, 43, 1528. 
 
3. Yakobson, G.G.; J. Gen. Chem. USSR, 1965, 35, 1158 
  
4. Watson, D. A.; Su, M. J.; Teverovsky, G.; Zhang, Y.; Garcia-Fortanet, J.; Kinzel, T.; 
Buchwald, S. L. Science, 2009, 325, 1661. 
 
5. Fuyura, T.; Strom, A. E.; Ritter, T. J. Am. Chem. Soc. 2009, 131, 1662. 
 
6. Tang, P. P.; Ritter, T. Tetrahedron, 2011, 67, 4449. 
 
7. Fuyura, T.; Kaiser, H. M.; Ritter, T. Angew. Chem. Int. Ed., 2008, 47, 5993. 
 
8. (a) Clark, J. H.; Denness, J. E.; McClinton, M. A.; Wynd, A. J. J. Fluorine Chem. 1990, 
50, 411. (b) Bozell, J. J.; Vogt, C. E. J. Am. Chem. Soc. 1988, 110, 2655. (c) Yang, S. 
H.; Li, C. S.; Cheng, C. H. J. Org. Chem. 1987, 52, 691. (d) Takagi, K.; Hayama, N.; 
Inokawa, S. Bull. Chem. Soc. Jpn. 1980, 53, 3691. (e) OʼConnor, K. J.; Burrows, C. J. 
J. Org. Chem. 1991, 56, 1344. (f) Arnold, J. T.; Bayraktaroglu, T. O.; Brown, R. G.; 
Heiermann, C. R.; Magnus, W. W.; Ohman, A. B.; Landolt, R. G. J. Org. Chem. 1992, 
57, 391. (g) Bayraktaroglu, T. O.; Gooding, M. A.; Khatib, S. F.; Lee, H.; Kourouma, 
M.; Landolt, R. G. J. Org. Chem. 1993, 58, 1264. (h) Vol, S.; Vivier, L.; Pérot, G. J. 
Mol. Catal. A.: Chem. 2001, 172, 241. (i) Imhaoulene, S.; Vivier, L.; Guisnet, M.; 
Pérot, G. Tetrahedron 1994, 50, 12913. (j) Meyer, G.; Rollin, Y.; Perichon, J. 
Tetrahedron Lett. 1986, 27, 3497. (k) Bonnichon, F.; Grabner, G.; Guyot, G.; 
Richard, C. J. Chem. Soc., Perkin Trans. 2 1999, 1203. (l) Klapars, A.; Buchwald, S. 
L. J. Am. Chem. Soc. 2002, 124, 14844. 
 
9. Fier, P. S.; Hartwig, J. F. J. Am. Chem. Soc., 2012, 134, 10795. 
 
10. Arvela, R. K; Leadbeater, N. E. Synlett, 2003, 8, 1145. 
 
11. Leadbeater, N. E.; Torenius, H. M. J. Org. Chem., 2002, 67, 3145 
	   28 
Preparation of 
Trifluoromethyl Ketones 
 
Chapter 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   29 
Recently the trifluoromethyl ketone (TFMK) has been exploited for its biological 
and chemical properties. They exhibit biological activity and have been used as 
inhibitors in the study of disorders such as severe acute respiratory syndrome (SARS)1 
and cystic fibrosis.2 Secondly, TFMKs are intermediates for the production of many 
trifluoromethylated heterocycles, which are synthetically useful in drug design. 
TFMKs as Biologically Active Molecules:	   
One significant property of TFMKs is the readiness to 
form a hydrate in aqueous conditions. This is mimicked with a 
serine or cysteine of an enzyme to form a hemiketal (52) or 
hemithioketal. The trifluoromethyl ketone is a competitive 
inhibitor of the enzyme, which stops its biological function.3 This has been exploited for 
certain viruses, diseases, and complications caused by serine and cysteine proteases.2 
The mechanism of action is through a nucleophilic attack by the active site of these 
proteases onto the electron-poor carbonyl carbon. Hemiketals and hemithioketals are 
formed from the nucleophilic attack of serine and cysteine proteases respectively 
rendering them inactive.2  
Proteases, which contain serine and cysteine active sites, are inhibited by 
aldehydes. Hemiacetals are readily formed with serine or cysteine as a result of a 
hydrated aldehyde to the enzyme. This mimics the intermediate of hydrolyzed peptides 
and may be noted as “transition state analogue inhibitors.”4 However, aldehydes are 
limited to the carboxyl terminus of peptides and therefore may only be effective for a 
Figure 4.1: Hemiketal with 
Serine 
OH
O
NH2
OR
HO CF3
52 
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smaller amount of proteases. Ketones may also be inhibitors but are not easily hydrated, 
this can be circumvented with the introduction of fluorine.4 Functionalities readily 
hydrated have been exploited in drug discovery. Trifluoromethyl ketones have been 
used as inhibitors for diseases such as cystic fibrosis,2 severe acute respiratory 
syndrome (SARS)1, and inflammatory disorders.5 
TFMKs as Intermediates in Drug Design: 
The trifluoromethyl ketone is not only a biological inhibitor, it is also used as a 
building block for the incorporation of the trifluoromethyl group into many cyclic and 
heterocyclic compounds. Heterocycles are often cores in many biologically active 
compounds due to an increase of solubility and other drug-like properties. Scheme 4.1 
shows a selection of the compound classes that can be derived from TFMK starting 
materials (54-59).6 
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The synthesis of the blockbuster AIDS medication Sustiva (62) produced by 
Bristol-Myers Squibb involves the introduction of the trifluoromethyl group to the 
molecule through a TFMK intermediate. This pathway is depicted in Scheme 4.2.7 
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Scheme 4.1: TFMK as Intermediates 
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Previous Methods for Synthesis of Trifluoromethyl Ketones: 
 The major methods for TFMK synthesis can be categorized into three different 
classes: acetylation of trifluoromethyl esters, oxidation, and nucleophilic addition via 
(trifluoromethyl)trimethylsilane (TMS-CF3). Although each pathway is effective for 
specific substrates, they all have disadvantages. Since the original work in the 1950ʼs,8 
the most preferred method was acetylation of trifluoroacetic acid derivatives.9 However, 
yields and reaction scope may be limited. The range of trifluoromethylated compounds 
produced depends upon the availability of the organometallic reagents. Also, yields can 
be diminished through double-alkylation by-products. This may be hindered by careful 
addition of the organometallic reagent. Grignard,8 organo lithiums,8 zinc,10 cadmium,8 
and manganese11 reagents all have been reported as suitable alkylating agents for a 
variety of trifluoromethyl starting materials such as: alkylfluoroacetates,8 anhydrides,12 
amides,13 and trifluoroacetonitriles. 10 
Another method is the oxidation of α-trifluoromethyl alcohols. The first apparent 
disadvantage is that it is a two-step process to the ketone. Secondary CF3 carbinols 
Scheme 4.2: Synthesis of Sustiva 
O
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OMe
Ph OH
H
n-BuLi
N
OHCl
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F3C
O
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60 61 62 
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must first be synthesized from an aldehyde precursor followed by subsequent oxidation. 
Usually this oxidation requires harsh conditions.14 Traditional methods of oxidation have 
been reported, however these are substrate specific and there may be complications 
with reproducibility.15 Dess-Martin periodinane is a reliable oxidant tolerant to a broad 
range of functionality but is quite costly and caution must be used when dealing with this 
shock-sensitive reagent.14 Recently, the Leadbeater group has published an alternative 
route utilizing a recyclable, green oxidation of CF3 carbinols (63) with an oxoammonium 
salt (64) as shown in Scheme 4.3.16 
 
 
 
 
(Trifluoromethyl)trimethylsilane: 
The production of trifluoromethyl ketones through nucleophilic attack by the 
trifluoromethyl anion has boomed since the early 1990ʼs with the utilization of 
(trifluoromethyl)trimethylsilane (TMS-CF3) (70). This is commonly known as the 
Ruppert-Prakash reagent. Ingo Ruppert first synthesized TMS-CF3 in 1984 from 
Scheme 4.3: Oxidation of CF3 Carbinols 
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NHAc
O BF4
2
N
CH2Cl2, rt,
O
CF3 N
NHAc
O
2
20 examples
49-99% yields 66 
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trimethylsilyl 
chloride and 
trifluoromethyl 
bromide in the 
presence of hexaethyl phosphorus triamide (Scheme 4.4). 17  Surya Prakash, and 
George Olah applied it to a range of aldehydes and ketones in 1989. 18 
Initiation of the reaction occurs with a catalytic amount of tetrabutylammonium 
fluoride (TBAF); a fluoride source for the production of the trifluoromethide ion. 
Nucleophilic attack of the CF3 group onto the carbonyl carbon produces an alkoxide. 
The alkoxide acts as a nucleophile towards TMS-CF3 for the liberation of another 
trifluoromethide ion resulting in a silylated ether. Hydrolysis of the ether with acid 
generates the desired CF3 carbinol.18 This significant finding was of great importance for 
the field of trifluoromethylation. Previously, Lewis acid catalyzed reactions from carbonyl 
species were not possible with trifluoromethide-metal complexes. The catalyst would 
form a M-F bond, decomposing the CF3 anion into a difluorocarbene without product 
formation.19 Scheme 4.5 illustrates the range of alcohols (72) that are formed by 
Prakashʼs method. Since 1989, reports of 
trifluoromethylation via TMS-CF3 have 
been shown to add at carbon, nitrogen, 
phosphorus, and sulfur centers.19  
 
R1 Y
O 1) TMS-CF3,TBAF,
1-24 h, THF
2) 0.5-1.0 N HCl
R1 CF3
Y OH
Y = H, R2 12 examples,
60-92% yield
Scheme 4.5: Prakashʼs Synthesis of CF3 Carbinols 
71 72 
TMS Cl Br CF3 N P N
N
TMS F
F F
67 68 69 70 
Scheme 4.4: Synthesis of TMS-CF3 
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Prakash reported the 
synthesis of trifluoromethyl ketones 
through CF3 initiation in 1998. 
Starting methyl esters (73) were 
converted to product (74) with 
2.5% TBAF and TMS-CF3 at -78 oC 
(Scheme 4.6). Reaction yields 
were moderate to excellent (68-
95%). Disadvantages to this method include the need for an inert atmosphere and 
rigorously dried solvents. Also, the temperature must be carefully controlled. When 
charging the flask with the initiator, the reaction mixture must be cooled to -78 oC. 
Reactions conducted with greater temperatures produced the desired ketone as well as 
a bis-trifluoromethylated by-product. This method was tolerant of aliphatic, aromatic, 
and α-β unsaturated systems. Alkynes were unreactive. 20 
Realizing the 
limitations of the TFMK 
synthesis via the Prakash 
route, the Shreeve lab had 
sought to create a more 
facile transformation.21 They 
suggested that rigorous 
drying of the reactants and 
74 
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O
1) 1 mol% CsF
1.02 equiv. TMS-CF3, rt.
2) HCl
0.5-4h,  84-90%
R1 CF3
O
R1 = R2 = Me, Et
PhPh
75 74 
74h 74i 74j 
74k 74l 74m 
Scheme 4.7: Shreevesʼs Synthesis of TFMK 
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R1 OMe
O
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2.5 mol% TBAF, -78 oC pentane
2) HCl
18-72 h, 68-95%
R1 CF3
O
R =
O2N
Ph 12
74a 74b 74c 74d 
74e 74f 74g 
Scheme 4.6: Prakashʼs Synthesis of TFMK  
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solvent was needed due to a competing reaction of water with TMS-CF3 producing 
CF3H. As a control experiment they mimicked Prakashʼs procedure in the presence of 
TBAF with <5% water by weight. The TMS-CF3 had quantitatively reacted to form HCF3 
and HOSi(CH3)3  which confirmed their hypothesis.21 Ketones and aldehydes are more 
reactive than esters. Therefore, anhydrous conditions were not necessary when 
Prakash reported the synthesis of trifluoromethyl alcohols. Upon many initiators 
screened, cesium fluoride was chosen as the best fluoride source for the 
trifluoromethylation of esters (Scheme 4.7). Most reactions were performed neat and at 
room temperature. For the cases of solid starting materials such as 74m, glyme was a 
used as a solvent.22 Neat reaction conditions may cause complications during scale-
up.21  
The mechanism for the 
transformation to TFMKs via 
TMS-CF3 occurs through 
initiation by a catalytic amount 
of fluoride, propagation, and 
hydrolysis to the ketone.  
Prakash suggests that a CF3 
transfer to the ester first occurs 
from a direct reaction of the 
fluoride source with TMS-CF3.19 
The initiation step most likely 
R1 O
O
R2
TMS-CF3
Initiator R O
O Si CF3
Initiation
F
TMS-F
R1 O
F3C O
R2
TMS-CF3
R1 O
F3C O
R2
F
R1 CF3
O
R2
Si
CF3
75 76 
77
 74 
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Figure 4.2: Prakashʼs Suggested Mechanistic Pathway19 
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occurs in a concerted fashion rather than liberating the trifluoromethide ion, producing 
alkoxide 77. Propagation of the reaction occurs through a trifluoromethyl transfer to 
another starting ester. The silylated ether (78) can then be cleaved by acid to the 
desired trifluoromethyl ketone (Figure 4.2).19  
A Weinreb Amide Approach: 
 Given the advantages of trifluoromethyl ketones, this functionality has become a 
subject of great interest in our laboratory. Of the three main approaches to TFMK 
synthesis we have explored in detail the use of TMS-CF3 as the trifluoromethyl source. 
Although it has been reported to act as a trifluoromethylating agent for many carbonyl 
compounds, the only productive starting functionality for TFMK synthesis is an ester.  
The methods reported by Prakash and Shreeve do contain limitations of over-addition 
and possible solubility and scalability complications.20,21 Therefore, our intentions were 
to investigate the use of other starting materials to produce trifluoromethyl ketones in a 
controlled fashion.   
 The Weinreb amide 
became a functionality of interest 
for our study. Weinreb and co-
workers exploited these N-
methoxy-N-methyl amides for the 
production of ketones via alkylation 
reactions in 1981.23  Previous to Weinrebʼs research, organo lithium, and Grignard 
R LG
O R'M
R N
O
O R'M
R N
O
O
R'
M
H3O
R R'
O
R' R'
R OH
Weinreb Amide
Over alkylation
Scheme 4.8: The Weinreb Amide 
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reagents were used for alkylation reactions of carbonyl compounds containing leaving 
group functionalities (79). Unfortunately, with esters, only double-alkylated products 
were formed (80). Scheme 4.8 depicts how using the Weinreb amide forced the 
reaction pathway towards the desired ketone. Nucleophilic attack of the alkyl reagent 
results in the tetrahedral 
intermediate 82, which is 
coordinated by the metal. 
This is a stable species, and 
can be hydrolyzed to 
produce the desired ketone 
(83). Since the intermediate 
cannot be further alkylated, 
double-addition by-products 
were not observed. 23 
Our hypothesis was 
that we could utilize Weinreb 
amides for the production of 
trifluoromethyl ketones 
without producing the 
corresponding bis-
trifluoromethyl alcohol. 
Previous reports suggested Table 4.1: Activated Imides and Amides 
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Product Yield 
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that amides were not prone to nucleophilic attack of the trifluoromethide group. Simple 
amides were unreactive with TMS-CF3 even when a stoichiometric amount of initiator 
was used.24 The carbonyl is deactivated through the lone pair of electrons on nitrogen. 
Susceptibility for attack can be increased if an electron-withdrawing substituent is added 
to the amide or a more activated system is used. Table 4.1 depicts an activated amide 
(84) and imides (85-88) that did react with trifluoromethyl trimethylsilane.25 Shreeve and 
co-workers reported another promising discovery. They had witnessed an exothermic 
reaction when N,N-dimethylbenzamide and dimethylacetamide were treated with TMS-
CF3 and CsF. No results were ever published on this finding suggesting the reaction 
could not be controlled.22 
We believed Weinreb amides would be suitable starting materials for 
trifluoromethylation reactions. Pre-coordination of the TMS-CF3 could facilitate reactivity, 
by moving electron density away from the carbonyl. The intermediate could then be 
exploited for a single trifluoromethyl addition.  
Results and Discussion for a Weinreb Amide Approach: 
 Our initial reaction conditions mimicked the standard procedure of 
trifluoromethylation from aldehyde and ketone precursors.26 Prakashʼs method reacted 
the starting materials with TMS-CF3, TBAF as initiator, and THF as solvent. Our 
reactions were tested on a 1 mmol scale with 1.3 equivalents of TMS-CF3 and 20 mol% 
of initiator at 0 oC. Potassium fluoride, sodium fluoride, cesium fluoride, and TBAF were 
all screened as initiators (Table 4.2, entries1-4). In the case of TBAF, only 5 mol% was 
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used as it is a soluble fluoride source. We had believed that the reaction would proceed 
in a one-pot, two-step fashion to first produce a silylated intermediate, which could be 
further cleaved to the ketone. No reaction was observed with potassium or sodium 
fluorides (Table 4.2, entries1-2).26 This is most likely due to low solubility of the salts in 
organic solvents. Low conversions of 12% and 55% to the trifluoromethyl ketone 
respectively were observed with TBAF and CsF as initiators (Table 4.2, entries 3-4). 
Thinking that low solubility of CsF may be impeding the reaction, other polar solvents 
such as acetonitrile and dichloromethane were screened (Table 4.2, entries 5-6). 
Unfortunately, inferior conversions were observed. Cesium fluoride was deemed the 
best initiator however much progress was needed to optimize reaction conditions to 
quantitative conversions.26 
 
 
 
 
 
 
 
To understand further the reactivity in THF, we screened other substrates. It was 
determined that the reactivity differed. Over time amide 94 converted to the TFMK 
(Table 4.2, entry 4). Yet with amide 97 only the intermediate was detected (Table 4.3). 
Table 4.2: Initial Trials 
!
Entry Initiator TMS-CF3 (equiv.) 
Solvent 
(0.7M) Time 94 95 96 
1 NaF 1.3 THF 17 h 100% 0% 0% 
2 KF 1.3 THF 17 h 100% 0% 0% 
3 TBAF 1.3 THF 17 h 88% 0% 12% 
4 CsF 1.3 THF 17 h 45% 0% 55% 
5 CsF 1.3 MeCN 17 h 100% 0% 0% 
6 CsF 1.3 DCM 17 h 89% 11% 0% 
94 95 96 
N
O
OMe N OMe
F3C OTMS
CF3
O
TMS-CF3, 
initiator, 0 oC, 17h
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For this substrate the reaction was 
reversible, as after time it would 
revert back to starting material. The 
reaction was monitored for 
conversion over time. The highest 
conversion of intermediate 98 
observed was 33% after 10 
minutes (Table 4.3, entry 3). When monitored hours later, only starting material was 
present (Table 4.3, entry 5). We believed that polar solvents were stabilizing the CF3 ion, 
and therefore a reverse reaction to liberate the trifluoromethide was possible.	   
 Understanding that polar solvents were not ideal for the reaction, we next looked 
at solvent-free conditions. The Shreeve group successfully produced TFMKs from 
esters under neat reaction conditions.21 We believed that an excess of TMS-CF3 in the 
absence of a polar solvent would facilitate product formation. Six equivalents of the 
reagent was chosen as a starting point on a 1.0 mmol scale, allowing enough volume to 
stir the reaction. To our delight, there was complete conversion to the tetrahedral 
intermediate. However, an uncontrollable exotherm was observed. Various approaches 
were taken to control the reaction. Lowering the temperature to -10 to -78 oC, and slow 
addition of 5-15 minutes of TMS-CF3 to the starting amides, were unsuccessful. Low 
temperatures of -78 oC were not productive and gradually warming up the reaction 
mixture resulted in an exotherm. Further optimization was needed.26   
O
N OMe
CsF, TMS-CF3,
THF, 0 oC N
F3C OTMS
OMe
6 697 98 
Table 4.3: Timed Trials 
! Entry Time 97  98  
1 0 min 100% 0% 
2 5 min >100% Trace 
3 10 min 66% 33% 
4 20 min 70% 30% 
5 4 h 100% 0% 
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Our next efforts were focused on selecting a co-solvent to dilute the reaction and 
act as a heat-sink. From previous experiments we knew that a polar solvent may be 
problematic and reversible. Therefore, we chose to screen non-polar solvents. Our 
primary attempts screened pentane, hexanes, and toluene as co-solvents on a 1-mmol 
scale at room temperature. Near quantitative conversion to the intermediate was 
observed. However, complications arose upon scale-up to 5 mmol. We were 
encouraged to find that cooling the contents to 0 oC before addition of TMS-CF3 resulted 
in an easily handled reaction without intense exothermic activity.26 
With the ability to contain the exotherm, we went on to examine loadings of 
initiator and TMS-CF3. Initially we were running the reaction in 6 equiv. of trifluoromethyl 
trimethylsilane. This is not desired as larger scale reactions could become quite 
expensive. Table 4.4 summarizes the trials. Lowering the amount to 3 equiv. was just 
as effective (Table 4.4, entry 3), and 2 equiv. resulted in acceptable conversion of 84% 
(Table 4.4, entry 2). Further reducing the loading resulted in incomplete reactions 
(Table 4.4, entry 1). A decrease to 10 mol% CsF resulted in sub-optimal conversion to 
95 of 67%. After longer reaction times of 24 hours, we were able to charge 2 
equivalents of TMS-CF3 and 20 mol% CsF to produce optimized conditions, which 
resulted in near quantitative conversions to the tetrahedral intermediate (Table 4.4, 
entry 5).26 
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Our next objective was to transform the silylated ether to the desired 
trifluoromethyl ketone. Prakash and Shreeveʼs methods cleaved the intermediate with 
acid. To our surprise, the intermediate was quite robust in acidic conditions. We then 
attempted to use a fluoride reagent, TBAF, as a cleavage source. Initially, the cleavage 
step was performed at room temperature with a stoichiometric amount of TBAF. An 
equal amount of water to TBAF was added to act as a proton source for the liberated N-
methoxy-N-methyl amine. Due to cost of the reagent, we also attempted using a 
catalytic amount of TBAF. Although it was successful for some substrates (Table 4.5, 
entry 3), it was not compatible with all (Table 4.5, entry 6). Some substrates were even 
resistant to cleavage with a stoichiometric amount of TBAF (Table 4.5, entry 4). Stirring 
the reaction for 2 hours at 50 0C allowed for optimal conversion of each intermediate 
produced to the trifluoromethyl ketone (Table 4.5, entry 5).26 
N
O
OMe N OMe
F3C OTMS
CF3
O
TMS-CF3, 
initiator, 0 oC
94 95 96 
Table 4.4: Optimization Experiments 
!
Entry Initiator TMS-CF3 (equiv.) Solvent Time 94 95 96 
1 CsF 1.0 Toluene 17 h 36% 63% 0% 
2 CsF 2.0 Toluene 17 h 16% 84% 0% 
3 CsF 3.0 Toluene 17 h 10% 90% 0% 
4 CsF 6.0 Toluene 17 h 9% 91% 0% 
5 CsF 2.0 Toluene 24 h 5% 95% 0% 
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Optimized conditions to perform the trifluoromethylation reaction involve a one-
pot two-step process. The Weinreb amide (5.0 mmol) in toluene (2.5 mL) is cooled to 0 
oC. To the flask are added 20 mol% of CsF followed by 2.0 equivalents of TMS-CF3. 
The reaction is stirred overnight (18-24 hours) and monitored by 1H NMR for 
completeness. Once a quantitative conversion to the intermediate is confirmed, a 
stoichiometric amount of TBAF and equal volume of water is added directly to the 
reaction flask and the resultant mixture heated to 50 oC for 2 h. A simple ether extraction 
and water wash allowed for the crude product. The pure products were isolated by 
column chromatography or distillation.26 
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99 100 
Table 4.5: Optimized Cleavage 
R N OMe
F3C OTMS
TBAF/H2O
R CF3
O
!
Entry R TBAF (equiv.) Time Temp. Conversion 
1 
 
1.0 2 h 23 oC >99% 
2 
 
0.5 2 h 23 oC >99% 
3 
 
0.1 2 h 23 oC 85% 
4 
 
1.0 18 h 23 oC 0% 
5 
 
1.0 2 h 50 oC >99% 
6 
 
0.1 2 h 23 oC 30% 
7 
 
1.0 2 h 50oC >99% 
O
O
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With optimal conditions at hand, we then probed the substrate scope of the 
reaction. As shown in Table 4.6 we were able to produce a variety of aryl, alkyl, and 
heterocyclic trifluoromethyl ketones with yields as high as 99% (Table 4.6, TFMK 115). 
Our methodology was tolerant of electron donating (Table 4.6, TFMK 96, 112) and 
electron withdrawing substituents (Table 4.6, TFMK 101-102) on the meta and para 
positions of aryl compounds. Heterocycles such as thiophenes, pyridines, and furans, 
are also compatible with this methodology (Table 4.6, TFMK 113, 114, 119). However, 
pure hydrate rather than the TFMK was isolated from the 4-pyridyl system due to an 
electron withdrawing nature of the system (Table 4.6, TFMK 114).26 
To continue our investigation of reaction scope, we turned to substituted and 
unsubstituted aliphatic compounds (Table 4.6, TFMK 104-111, 116-118). Initial 
complications of this methodology became apparent in the isolation and purification 
steps. Addition of the trifluoromethyl group generally increases the volatility of the 
ketone products compromising reaction yield. Therefore, larger alkyl chains and phenyl 
substituted aliphatic compounds were preferred. Due to a lack of chromophores, many 
of the alkyl systems had little or no UV activity. Products were also unreactive to stains 
limiting the purification process to distillation.  
Originally the reactions were run on a 5 mmol scale, however scale-up was 
required for a fruitful distillation. When reactions were increased to 10-15 mmol, an 
exotherm was observed after the TMS-CF3 was added. We were delighted to find that 
diluting the reaction from 2.0 M to 0.5 M controlled the exotherm, even when conducted 
at room temperature. The increased volume of toluene, slowed the cleavage step from 2 
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h to overnight. Therefore, the toluene was removed in vacuo prior to TBAF addition. As 
mentioned for some of the lighter aliphatic systems, reaction yield was diminished due 
to high volatility. A greater percent of TFMK could be observed if all of the toluene was 
removed prior to the cleavage step. Ether or hexanes may be used as a replacement 
solvent. The alkyl substrates were converted to the desired ketones in 49-76% yields 
(Table 4.6, TFMK 104-111, 116-118). Slightly lower reaction yields were due to isolation 
processes.26 
TFMK Product Yield TFMK Product Yield 
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O
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111 O CF3
O
 
51% 123 O CF3
O
 
51% 
 
We also performed our method with α,β-unsaturated amides (Table 4.6, TFMK 
120-123). Diminished yields of the trifluoromethyl ketones were observed due to the 
production of a side-product.  Mass spectrometry and NMR analyses confirmed a 1,4-
Michael addition of the N-methoxy-N-methyl amine to the trifluoromethyl ketone (Table 
4.7, compound 126). This was first observed with the unsubstituted cinnamic acid 
derivative 120 when a low TFMK yield of 22% was acquired. The Michael adduct was 
isolated in 63%, with a ratio of TFMK to by-product of 25:75 (Table 4.7, TFMK 120). 
The weakened olefin is susceptible to 1,4 addition of the amine produced.26 
 It was thought that adding acid to the cleavage step could hinder by-product 
formation. In theory, the nitrogen of the N-methoxy-N-methyl amine liberated could be 
Table 4.6: Substrate Scope 
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protonated and inhabit the aqueous phase. To our surprise, a biphasic TBAF/ 6 N HCl 
did not affect 1,4-addition. We then attempted to skew product ratio through an 
electronic effect. Systems with an electron withdrawing substituent should weaken the 
double bond favoring amine attack. Contrastingly, an electron-donating group will 
increase electron density to the olefin, reducing the probability of Michael addition. We 
investigated this hypothesis with different electron donating and withdrawing 
functionalities as shown in Table 4.7. Initially, we believed that the presence of an 
electronegative fluorine in the para-position would favor the 1,4 addition product. 
However, the ratio of TFMK to Michael adduct was 41:59 (Table 4.7, TFMK 122). This 
is not surprising as fluorine may also have a donating effect from its lone pairs of 
electrons. Increasing the electron donating power onto the alkene resulted in a greater 
percentage of TFMK to side product as expected. The para-methoxy substrate  
produced a ratio of 55:45 TFMK to 1,4 adduct (Table 4.7, TFMK 121), and the furyl 
substrate resulted in a ratio of 71:29 in favor of the trifluoromethyl ketone (Table 4.7, 
TFMK 123). It is important to note that all of the 1,4-adducts isolated existed as part 
ketone and part hydrate that were inseparable by chromatography. The ratios calculated 
are of the desired TFMK to combined 1,4 adduct and its hydrate.26 
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Unfortunately, the α,β-unsaturated amides were not the only incompatible 
substrates with our method. Table 4.8 summarizes the problematic compounds. Ortho-
substituents on aryl rings were not tolerated. This was first discovered with the o-
methoxy amide (Table 4.8, amide 128). Conversion to the intermediate was minimal, 
which over time would self-cleave to the TFMK. As with any complication of organic 
chemistry this low reactivity could either be contributed by a steric or electronic effect. 
We initially hypothesized the former based on the 88% isolated yield obtained with the 
chemically similar para-methoxy substrate. In order to support our theory, we conducted 
an experiment with the ortho nitro amide 129 as a contrasting electron-withdrawing 
group. No reaction occurred suggesting that electronics was not hindering the reactivity 
(Table 4.8, amide 129). We then sought to see if any ortho substituent would be 
R N OMe
TMSO CF3 TBAF/ H2O
2 h, rt R
O
CF3 R CF3
ONMeO
124 125 126 
Product R TFMK:1,4 TFMK Yield 
120 
 
25:75 22% 
122 
 
41:59 41% 
121 
 
55:45 47% 
123 
 
71:29 51% !
F
MeO
O
Table 4.7: Investigation of Michael Adducts 
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tolerated with the 2-methyl amide (Table 4.8, amide 127). Again, little or no product was 
generated. Even this small steric interaction dramatically decreased the reactivity.26 
Steric issues were again 
apparent with branched 
aliphatic substrates. The 
presence of a substituent alpha 
to the carbonyl was not 
accepted as can be shown with 
the branched ethyl chain of 
substrate (Table 4.8, amide 
132). In comparison, the 
straight octyl chain led to a high 
conversion of the intermediate 
(85-90%) and the TFMK 
product (58% yield). We then 
attempted reactions with 
differing groups beta to the 
carbonyl. The branched phenyl 
derivative was not reactive 
(Table 4.8, amide 134), compared to the de-branched, which generated a 68% yield of 
TFMK 110. It was not until we decreased the steric hindrance to a methyl group in this 
position was conversion to the intermediate observed. Even then, only partial 
Table 4.8: Problematic Substrates 
Amide Substrate Conversion 
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transformation to the intermediate of 55-60% occurred, resulting in a compromised yield 
of TFMK 118 in 48%.26  
The steric limitation of the reaction hints towards the mechanism. In our method 
we believed that either one of two initiation pathways are plausible. Initially we 
suggested that the cesium fluoride activated this reaction. This reagent would act as a 
dual contributor to the reaction as an initiator, and chelator. This chelation would result 
in the 5-membered transition state, increasing the electrophilicity of the carbonyl. 
However, evidence from our studies points away from this theory.  
When screening initiators, we did see some conversion with TBAF as an initiating 
source.  Literature precedent suggests that amides must be activated in order to react 
with TMS-CF3.24,25 If chelation really was as important for this reaction as believed, there 
would be no conversion with TBAF due to a lack of metal or chelating source. In 
addition, this does not explain the steric limitations of the reaction. The Shreeve group 
had suggested that TMS-CF3 was responsible for precoordination with starting esters 
even in the presence of CsF. Our results can be explained by this theory. Figure 4.3 
illustrates this precoordinated transition state (135 or 136). Just as a chelation effect, the 
TMS-CF3 could allow for amide activation. Therefore, conversion to the intermediate 
would be possible when using a non-metal fluoride source such as TBAF. The transition 
state also contributes a large steric bulk around the electrophilic carbon. Increasing 
density around this site with an ortho substituent, or alpha branching would result in a 
dramatic decrease in reactivity as observed.    
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Once precoordination occurs, the fluoride ion then reacts with TMS-CF3 for the 
liberation of the trifluoromethyl group. Shreeve suggests that this occurs in a concerted 
like fashion, where the nucleophilic attack onto the carbonyl occurs instantaneously to 
generate an alkoxide ion 137.22 This further propagates the reaction by interacting with 
another TMS-CF3 to produce a silylated ether.  The resulting intermediate is an isolatable, 
stable moiety as confirmed with our p-tBu substrate (138). After conversion to the 
intermediate, we then filtered the reaction and removed the solvent to produce an 86% 
yield of the silylated ether. The compound was stable at room temperature without any 
noticeable degradation even when monitored months later. Nonetheless, once 
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Figure 4.3: Our Suggested Mechanistic Pathway 
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converted to the intermediate the substrates were immediately introduced to a 
stoichiometric amount of fluoride to form the desired TFMK in a one-pot fashion.26 
Summary: 
In summary, this methodology is a novel way for the production of trifluoromethyl 
ketones. It is the first report for the introduction of the CF3 group into an amide to form a 
TFMK. Over trifluoromethylation was never detected. The reaction may be performed at 
room temperature under dilute conditions without the need for anhydrous conditions or 
an inert atmosphere. Although the methodology is limited to less-hindered substrates, 
we have demonstrated a successful method with aryl, aliphatic, and heterocyclic starting 
amides with up to quantitative yields. 
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(Difluoromethyl)trimethylsilane: 
Trifluoromethyl trimethylsilane has been a dependable trifluoromethylating 
reagent since its synthesis in 1984.1  The difluorinated analogue, TMS-CHF2 (140), 
however  has seen little use as a difluoromethylating reagent. It was not until 1995, that 
TMS-CHF2 was applied towards fluoroalkylation reactions.2 Hagiwara and Fuchikami 
were pioneers for the 
difluoromethylation of 
aldehydes to CF2 alcohols 
(Scheme 5.1).2	   
Hagiwara and Fuchikami began their work repeating the procedure for 
trifluoromethylation with TMS-CHF2.1b  Benzaldehyde and TBAF (0.6 mol %) were added 
to THF and the reaction mixture stirred at room temperature for 24 h.2 No reaction was 
noted using this procedure. Molecular orbital calculations (MOPAC) were employed to 
understand the reactivity differences between each fluoroalkylating reagent. The 
nucleophilic attack of a fluoride onto the silicon forms pentavalent silicate intermediates 
(142).  The bond order between the silicon and carbon intermediates 
were calculated for TMS-CHF2 (0.436) and TMS-CF3. (0.222).2 This 
increase in bond character of the TMS-CHF2 intermediate explains why 
the Si-C bond is more difficult to break. This means that harsher reaction 
conditions were necessary for difluoromethylation to occur. 
Si F F
X F
X = H,F
Figure 5.1: 
Silicate 
Intermediates 
142 
Scheme 5.1. Fuchikamiʼs Difluoromethylation 
R
O
H Me3Si
F
F
1) 5-50 mol% KF
DMF, 100 oC, 6-12h
2) HCl
R
OH
F
F
9 examples, 43-82%
139
 
140 141
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Benzaldehyde and KF (5-50 mol%) were added to DMF and heated to 100 oC for 6 h. 
The CF2 alcohol was isolated in an 82% yield. Ketones were also employed as starting 
materials but poor yields of 20-35% were reported.2  
	   Since the original report in 1995, limited attention has been focused on using 
(difluoromethyl)trimethylsilane as a fluoroalkylating reagent. However, in 2011, Hu et. al. 
reported alternative reaction conditions for the difluoromethylation of aldehydes and 
ketones.3 Different solvents, initiators, and temperatures were screened for the reaction 
of aldehydes with TMS-CHF2. In DMF, suitable initiators were CsF, KF/18-crown-6, and 
tetrabutylammonium difluorotriphenylsilicate (TBAT). Interestingly, when the solvent was 
changed to THF, potassium tert-butoxide (KOtBu) was a successful initiator, whereas 
TBAT was not. This is attributed to the greater solubility of KOtBu in THF than the other 
initiators screened. Nonetheless, the CsF/DMF system was chosen as it exhibited the 
best reaction conversions (Scheme 
5.2).3 Aryl, aliphatic, and conjugated 
aldehydes were isolated in 50-96% 
yields.3  
 The Hu group then sought to perform the difluoromethylation of ketones. When 
conducted using CsF and DMF (conditions developed for aldehydes) low yields of 30-
40% were reported.3 Reaction monitoring had suggested that an irreversible, 
nucleophilic difluoromethylation occurred with DMF compromising yields. Since the 
solvent was not ideal, they next screened THF and alkoxide initiators. Interestingly, non-
enolizable ketones proceeded to the CF2 alcohol with 2 equivalents of KOtBu at -78 oC. 
Scheme 5.2: Huʼs Difluoromethylation of Aldehydes 
R
O
H Me3Si
F
F
1)13% CsF
DMF, rt, 9h
2) TBAF
R
OH
F
F
12 examples, 50-96%
139
 
140
 
141
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A stoichiometric amount of the initiator was crucial for the reaction to occur. This 
suggests that the mechanism is not auto-
catalyzed by the alkoxide produced after 
addition of the CF2. Excellent yields of 95-
97% of the CF2 carbinols were generated, as 
shown with ketone 144.3  
The Difluoromethyl Ketone: 
 Since Huʼs 
breakthrough, 
DFMKs have 
notably not been 
synthesized via 
TMS-CHF2.3 
Hence, we have embarked upon the synthesis of DFMKs via a Weinreb amide 
approach. Initial screenings for DFMKs were accomplished prior to the optimization of 
trifluoromethyl ketones from Weinreb amides. (Difluoromethyl)trimethylsilane was 
freshly prepared from the reduction of TMS-CF3 with sodium borohydride. 4 We 
hypothesized the difluorination would occur through the silyl-intermediate 145 (Scheme 
5.4). A range of amides were screened with the following: THF, DME and DMF as 
potential solvents. The reaction was unsuccessful with catalytic amounts of CsF (20 
mol%) or KOtBu (20 mol%). Reaction times of 24 hours were employed with no 
conversion (Table 5.1, entries 1-4). This was discouraging as our trifluoromethylation 
R
O
N Me3Si
F
F
20 % CsF, THF
R
TMSO
F
FOMe
N
OMe
Me3Si
F
F
2 equiv. KOtBu, 
THF
>99% conversion
N
O
OMe
O
F
F
X
Scheme 5.4: Attempts towards Difluoromethylation 
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Scheme 5.3: Huʼs Difluoromethylation of Ketones 
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attempts exhibited minor conversions under these conditions. Nonetheless, we next 
mimicked conditions reported by Hu for difluoromethylation of ketones with the 
remaining TMS-CHF2 in hand. Amide 146 (1.0 mmol), TMS-CHF2 (1.3 equiv.), and 
KOtBu (2.0 equiv.) were added to THF. The reaction was cooled to 0 oC and left to stir 
overnight. To our delight, we observed near quantitative conversion to the difluoromethyl 
ketone (Table 5.1, entry 5). Due to time constraints the product was never isolated.  
 
 
 
Table 5.1: Experimental Attempts 
R
O
N Me3Si
F
F
Initiator,
solvent
R
TMSO
F
FOMe
N
OMe
81
 
140
 
145
 
!
Entry Amide R Solvent Initiator Conversion 
1 148 
 
DME 20 mol% CsF 0% 
2 146 
 
DMF 20 mol% CsF 0% 
3 149 
 
THF 20 mol% KOtBu 0% 
4 146 
 
DMF 20 mol% KOtBu 0% 
5 146 
 
DMF 200 mol% KOtBu 
>99% 
TFMK 
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TMS-CHF2 for 1,1-difluoro Alkenes: 
 We were  
interested in 
exploiting TMS-CHF2 
for the synthesis of 
other difluorinated 
functionalities. One 
reaction of interest 
was the Petersen olefination for the production of 1,1-difluoroalkenes. This method 
reacts ketones and aldehydes with α-silylcarbanions (150) to form substituted olefins 
(Scheme 5.5).5 Currently, this reaction has not been reported with TMS-CHF2 to yield 
1,1-difluoroalkenes. With no literature precedent on this transformation, we sought to 
investigate the reactivity of TMS-CHF2 for a Peterson-like reaction (Scheme 5.5). The 
silylated reagent could be deprotonated to form intermediate 156. In theory, this would 
then eliminate to form the desired CF2 alkene (157).  
To begin our investigation, we needed to find an appropriate base to deprotonate 
the TMS-CHF2. We hypothesized n-BuLi would be sufficient for this purpose. THF (1 
mL) was cooled to -78 oC. (Difluoromethyl)trimethylsilane (1.25 mmol) was added 
followed by the base (1 mmol). We waited for a period of 5 min for the deprotonation to 
occur. The aldehyde (158, 0.25 mmol) was then added to the flask in attempts to form 
the difluoro alkene. However, the desired product (159) was not observed. Instead, butyl 
addition into the aldehyde occurred (Table 5.2, entry 1).  These results suggest that the 
Scheme 5.5: The Peterson Olefination 
R1 R2
TMS Li
R3 R4
O
R4
O
TMS
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F
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F
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silylated reagent was not deprotonated. It is important to note that the solvent was dried, 
and base titrated before conducting the reaction. We next hypothesized that a stronger 
base may be needed for a successful reaction, so t-BuLi was tested. Again, the t-Bu 
group reacted with the aldehyde rather than the desired reagent (Table 5.2, entry 2).  
We next turned to tetramethylethylenediamine (TMEDA) as an additive. The TMEDA 
increases reactivity through disruption of the hexameric aggregation of n-BuLi. 6 
Unfortunately, only starting material was observed (Table 5.2, entry 3). In this instance, 
the TMEDA increases a steric bulk into the system, which may have hindered alkyl 
addition.  
 
We initially believed that deprotonation of a hydrogen on TMS-CHF2  would be 
facile because of the electronegative nature of fluorine. However, the literature explains 
why this proton abstraction did not occur. A carbon alpha to a difluoromethyl group may 
Si F
F H R-Li
 -78 oC, 
5min-90min
Si F
F Li O
O
H
O
O
O
H
F F
!
Entry Conditions Equiv. Time Temperature Product 
 
1 
 
n-BuLi 
 
1.0 
 
5 min 
 
-78 o C 
 
n-Bu addition 
2 
 
t-BuLi 
 
1.0 5min -78 o C t-Bu addition 
3 n-BuLi/ TMEDA 1.0 1.5 h -10 
oC -78 o C NR 
Table 5.2: The Peterson Olefination Attempts 
154 141
 
158 159 
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easily be deprotonated. However, deprotonation of a carbon directly attached to two 
fluorines is not. Repulsion of the lone pairs of electrons on the fluorine extremely 
destabilizes the carbanion.7 As a result, it is not known to deprotonate.7  
Summary:	   
 Difluorination of organic molecules has been a challenging task for synthetic 
chemists. A few of the significant breakthroughs have been accomplished with TMS-
CHF2 as a difluorinating reagent. We have attempted the synthesis of 1,1-
difluoroalkenes, and difluoromethyl ketones with TMS-CHF2. A Weinreb amide 
approach to DFMK seems promising, although more optimization is needed. 
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General Considerations: 
  
              All chemical transformations requiring inert atmospheric conditions or vacuum 
distillation utilized Schlenk line techniques with a 3- or 4-port dual-bank manifold. 
Nitrogen was used to provide such an atmosphere. NMR Spectra (1H, 13C, 19F) were 
performed at 298 K on either a Brüker Avance Ultra Shield 300 MHz NMR, Brüker DRX-
400 400 MHz NMR, or Brüker Avance 500 MHz NMR. 1H-NMR Spectra obtained in 
CDCl3 were referenced to residual non-deuterated chloroform (7.26 ppm) in the 
deuterated solvent or in deuterated methanol referenced to TMS (0.00 ppm). 13C-NMR 
Spectra obtained in CDCl3 were referenced to chloroform (77.3 ppm) or to deuterated 
acetone (29.84 ppm). 19F-NMR spectra were  referenced to hexafluorobenzene (–164.9 
ppm) 1 . Reactions were monitored by an Agilent Technologies 7820A Gas 
Chromatograph attached to a 5975 Mass Spectrometer, 1H-NMR, and/or by TLC on 
silica gel plates (60Å porosity, 250 μm thickness). High-resolution mass spectra were 
obtained using a JEOL AccuTOF-DART SVP 100 in positive direct analysis in real time 
(DART) ionization method, using PEG as the internal standard. TLC analysis was 
performed using hexanes/ethyl acetate as the eluent and visualized using 
permanganate stain, p-anisaldehyde stain, Seebachʼs Stain, and/or UV light. Flash 
chromatography and silica plugs utilized Dynamic Adsorbants Inc. Flash Silica Gel (60Å 
porosity, 32-63 µm).  
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Attempts towards Fluoroarenes: 
 
 
 
 
 
4-Bromoanisole from 4-Iodoanisole2:  
To a 10 mL microwave tube equipped with a stir bar was added 4-iodoanisole (41, 
0.235g, 1.0 mmol, 1.0 equiv.), followed by copper (II) bromide (0.246 g, 1.1 mmol, 1.1 
equiv.), and acetonitrile (1 mL). The tube was then capped and placed into the 
microwave cavity. The contents were ramped to 170 oC and let stir at temperature for 15 
minutes. Upon cooling, the reaction mixture was transferred to a separatory funnel and 
diluted with diethyl ether (20 mL). The mixture was washed twice with a brine solution (2 
x 20 mL). The organics were collected and the aqueous layer was extracted with a third 
portion of diethyl ether (20 mL). The combined organics were dried with magnesium 
sulfate and filtered. Internal standard 1,2,4,5-tetramethylbenzene (.0680g, 0.5 mmol, 0.5 
equiv.) was added to the flask and the solvent was removed in vacuo. 1H-NMR yield 
suggested full conversion to 4-bromoanisole (50) with 70% recovery by internal 
standard. 1H NMR (CDCl3, 400 MHz) δ ppm 3.83 (s, 3H), 6.84 (d, J = 9.00 Hz, 2 H), 
7.44 (d, J = 9.00 Hz, 2 H). 
 
 
70%
I CuBr2, solvent
MW 170 oC, 15 min
MeO
Br
MeO49 50 
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A Weinreb Amide Approach to Trifluoromethyl Ketones: 
Synthesis of Weinreb Amide Substrates: 
General Procedure A: Weinreb Amides From Acid Chlorides:3 
 
 
 
 
 
4-(tert-butyl)-N-methoxy-N-methylbenzamide4 (94) 
To a 250 mL round bottom flask equipped with a stir bar was added 4-t-butylbenzoyl 
chloride (7.867 g, 40 mmol, 1.0 equiv.), DCM (80 mL, 0.5 M in the acid chloride), 
followed by N-O-dimethylhydroxylamine hydrochloride (4.098 g, 42 mmol, 1.05 equiv.). 
The flask was cooled to 0 oC in an ice bath for 10 minutes. Pyridine (6.638 g, 84 mmol, 
2.1 equiv.) was added drop-wise to the flask over a period of 10 minutes. The reaction 
flask was taken out of the ice bath and upon warming, a white precipitate formed. The 
reaction was allowed to stir overnight. The reaction mixture was then diluted  with DCM 
(200 mL) and was transferred into a separatory funnel. The organic layer was washed 
with 2 x 120 mL of 1 M HCl, 2 x 140 mL of a saturated sodium bicarbonate solution, and 
1 x 120 mL of brine. The resulting organic solution was dried over Na2SO4, decanted, 
and the solvent was removed in vacuo by rotary evaporation to yield the pure Weinreb 
amide (7.91 g, 89%). 1H NMR (CDCl3, 500 MHz) δ ppm 1.30 (s, 9 H) 3.32 (s, 3 H) 3.54 
N
O
OMe
H2
N OMe
Cl
N
CH2Cl2, 0 oC -rt
Cl
O
160
 
94 
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(s, 3 H) 7.38 (d, J=8.83 Hz, 2 H) 7.60 (d, J=8.20 Hz, 2 H) 13C NMR (CDCl3, 125 MHz) δ 
ppm 31.32 (CH3) 34.06 (CH3) 34.97 (C) 61.13 (CH3) 125.07 (CH) 128.25 (CH) 131.24 
(C) 154.06 (C) 170.10 (C) GC-MS (EI) 221 ([M]+, .01%), 161 (100%), 146 (14%), 118 
(14%), 115 (8%), 91 (10%), 77 (6%). 
 
 N-methoxy-N-methyl-3-nitrobenzamide5(161) (5.83 g, 69%) was 
prepared according to the representative procedure from 3-
nitrobenzoyl chloride (7.423 g, 40 mmol) giving the pure Weinreb 
amide as an off-white solid.   1H NMR (CDCl3, 400 MHz) δ ppm 3.41 (s, 3 H) 3.56 (s, 3 
H) 7.61 (t, J=7.95 Hz, 1 H) 8.04 (d, J=7.58 Hz, 1 H) 8.33 (d, J=9.29 Hz, 1 H) 8.58 (s, 1 
H)   13C NMR (CDCl3, 125 MHz) δ ppm 33.48 (CH3) 61.60 (CH3) 123.75 (CH) 125.48 
(CH) 129.46 (CH) 134.58 (CH) 135.75 (C) 148.00 (C) 167.39 (C) GC-MS (EI) 210 ([M]+, 
2%), 150 (100%), 104 (39%), 92 (4%), 76 (33%), 75 (9%), 50 (11%), 43 (6%). 
 
 
3-bromo-N-methoxy-N-methylbenzamide(162)6 (3.26 g, 67%) was 
prepared according to the representative procedure from 3-
bromobenzoyl chloride (4.389 g, 20 mmol) giving the pure Weinreb 
amide as a colorless oil.   1H NMR (CDCl3, 500 MHz) δ ppm 3.35 (s, 3 H) 3.55 (s, 3 H) 
7.28 (t, J=7.88 Hz, 1 H) 7.59 (m apparent overlapping doublets, 2 H) 7.82 (s, 1 H) 13C 
NMR (CDCl3, 125 MHz) δ ppm 33.71 (CH3) 61.37 (CH3) 122.17 (C) 126.97 (CH) 129.81 
(CH) 131.38 (CH) 133.72 (CH) 136.14 (C) 168.33 (C) GC-MS (EI) 245 ([M]+2, 4%), 243 
N
O
OMe
NO2
N
O
OMe
Br
161
 
162
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([M]+, 4%), 185 (97%), 183 (100%), 157 (38%), 155 (39%) 76 (27%), 75 (22%), 74 (9%), 
50 (14%). 
 
N,4-dimethoxy-N-methylbenzamide5 (163) (7.05 g, 90%) was 
prepared according to the representative procedure from 4-
methoxybenzoyl chloride (6.824 g, 40 mmol) giving the pure Weinreb amide as a 
colorless oil.   1H NMR (CDCl3, 400 MHz) δ ppm 3.34 (s, 3 H) 3.55 (s, 3 H) 3.83 (s, 3 H) 
6.89 (d, J=9.05 Hz, 2 H) 7.72 (d, J=9.05 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 
34.14 (CH3) 55.56 (CH3) 61.13 (CH3) 113.49 (CH) 126.27 (C) 130.79 (CH) 161.77 (C) 
169.63 (C) GC-MS (EI) 195 ([M]+, 1%), 135 (100%), 107 (8%), 92 (12%), 77 (15%), 64 
(6%). 
 
N-methoxy-N,2-dimethylbenzamide 7  (127)  (4.42g, 75%) was 
prepared according to the representative procedure from 2-
nitrobenzoyl chloride (10.0 g, 60 mmol) giving the pure Weinreb amide as a clear 
colorless oil.   1H NMR (CDCl3, 500 MHz) δ ppm 2.27 (s, 3 H) 3.23 (br. s., 3 H) 3.43 (br. 
s., 3 H) 7.09 - 7.16 (m, 2 H) 7.16 - 7.25 (m, 2 H) 13C NMR (CDCl3, 125 MHz) δ ppm 
19.04 (CH3) 33.19 (broad, CH3) 61.00 (CH3) 125.38 (CH) 126.15 (CH) 129.16 (CH) 
130.11  (CH) 134.75 (C) 135.25 (C) 170.81 (C)   GC-MS (EI) 179 ([M]+, 1 %), 119 
(100%), 91 (60%), 65 (19%) 51 (3%) 
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N-methoxy-N-methyl-2-nitrobenzamide8 (129) (3.41 g, 85%) was 
prepared according to the representative procedure from 2-
nitrobenzoyl chloride (3.45 g, 22.17 mmol) giving the pure Weinreb 
amide as a yellow solid.   1H NMR (CDCl3, 500 MHz) δ ppm 3.26 (br. s., 3 H) 3.27 (br. s., 
3 H) 7.46 (d, J=7.57 Hz, 1 H) 7.53 (t, J=8.20 Hz, 1 H) 7.66 (t, J=7.60 Hz, 1 H) 8.06 (d, 
J=8.20 Hz, 1 H)  13C NMR (CDCl3, 125 MHz) δ ppm 33.41 (CH3) 61.39 (CH3) 123.93 (C) 
128.50 (CH) 130.19 (CH) 131.56 (CH) 134.14 (CH) 145.84 (C) 168.85 (C)  GC-MS (EI) 
210 ([M]+, 0.1%), 163 (1%), 150 (100%), 121 (17%), 104 (25%), 92 (10%), 78 (18%),  
77(14%), 76 (70%), 75 (15%), 74 (15%), 63 (10%), 51(53%)  
 
N,2-dimethoxy-N-methylbenzamide5 (128) (6.27 g, 80%) was 
prepared according to the representative procedure from 2-
methoxybenzoyl chloride (6.82 g, 40 mmol) giving the pure Weinreb amide as a off- 
yellow solid.   1H NMR (CDCl3, 500 MHz) δ ppm 3.26 (br. s., 3 H) 3.36 - 3.71 (m, 3 H) 
3.79 (s, 3 H) 6.88 (d, J=8.20 Hz, 1 H) 6.92 (t, J=7.88 Hz, 1 H) 7.22 (d, J=6.94 Hz, 1 H) 
7.30 (td, J=7.88, 1.70 Hz, 1 H) 13C NMR (CDCl3, 100 MHz) δ ppm 32.59 (CH3) 55.82 
(CH3) 61.10 (CH3) 111.24 (CH) 120.54 (CH) 125.37 (C) 127.74 (CH) 130.71 (CH) 
155.89 (C) 169.66 (C) GC-MS (EI) 195 ([M]+, 1%), 135 (100%), 120 (4%), 92 (18%), 77 
(26%), 51 (4%),  
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 N-methoxy-3-(2-methoxyphenyl)-N-methylpropanamide 
(164)   (7.78 g, 87%) was prepared according to the 
representative procedure from 3-(2-methoxyphenyl)propanoyl chloride (7.946 g, 40 
mmol) giving the pure Weinreb amide as a colorless oil.   1H NMR (CDCl3, 400 MHz) δ 
ppm 2.71 (t, J=7.25 Hz, 2 H) 2.95 (t, J=8.20 Hz, 2 H) 3.17 (s, 3 H) 3.61 (s, 3 H) 3.82 (s, 
3 H) 6.84 (d, J=7.57 Hz, 1 H) 6.88 (t, J=7.88 Hz, 1 H) 7.14 - 7.23 (m, 2 H) 13C NMR 
(CDCl3, 100 MHz) δ ppm 26.00 (CH2) 32.18 (CH2) 32.20 (CH3) 55.30 (CH3) 61.25 (CH3) 
110.33 (CH) 120.58 (CH) 127.57 (CH) 129.69 (C) 130.22 (CH) 157.65 (C) 174.41 (C) 
GC-MS (EI) 223 ([M]+, 11%), 163 (27%), 135 (17%), 121 (100%), 105 (7%), 91 (40%), 
77 (11%), 65 (7%), 44 (7%). HRMS (ESI+), calcd for C12H17NO3  [M+H]+ 224.1287, 
found: 224.1278 
 
 N-methoxy-N-methyl-3-(o-tolyl)propanamide (165) (2.31 g, 
68%) was prepared according to the representative procedure 
from 3-(o-tolyl)propanoyl chloride (3.00 g, 16.43  mmol) giving the pure Weinreb amide 
as a colorless oil.   1H NMR (CDCl3, 400 MHz) δ ppm 2.35 (s, 3 H) 2.70 (apparent triplet, 
J=8.10 Hz, 2 H) 2.96 (apparent triplet, J=8.00 Hz, 2 H) 3.20 (s, 3 H) 3.62 (s, 3 H) 7.06 - 
7.22 (m, 4 H) 13C NMR (CDCl3, 100 MHz) δ ppm 19.44 (CH3) 28.32 (CH2) 32.39 (CH3) 
32.73 (CH2) 61.39 (CH3) 126.30 (CH) 126.48 (CH) 128.96 (CH) 130.45 (CH) 136.20 (C) 
139.62 (C) 173.98 (C) GC-MS (EI) 207 ([M]+, 0.1%), 147 (6%), 119 (41%), 105 (100%), 
91 (17%), 77 (14%), 61 (32%), 39 (3%). HRMS (ESI+), calcd for C12H17NO2  [M+H]+ 
208.1338, found: 208.1313  
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 N-methoxy-3-(3-methoxyphenyl)-N-methylpropanamide 9 
(166)  (3.11 g, 60%) was prepared according to the 
representative procedure from 3-(3-methoxyphenyl)propanoyl 
chloride (4.86 g, 23.31 mmol) giving the pure Weinreb amide as a colorless oil.   1H 
NMR (CDCl3, 400 MHz) δ ppm 2.73 (apparent triplet, J=7.60 Hz, 2 H) 2.93 (apparent 
triplet, J=8.30 Hz, 2 H) 3.17 (s, 3 H) 3.60 (s, 3 H) 3.78 (s, 3 H) 6.74 (d, J=8.07 Hz, 1 H) 
6.77 (s, 1 H) 6.81 (d, J=7.58 Hz, 1 H) 7.19 (t, J=7.82 Hz, 1 H) 13C NMR (CDCl3, 100 
MHz) δ ppm 30.89 (CH2) 32.36 (CH3) 33.85 (CH2) 55.30 (CH3) 61.38 (CH3) 111.57 (CH) 
114.36 (CH) 120.94 (CH) 129.61 (CH) 143.14 (C) 159.86 (C) 173.84 (C) GC-MS (EI) 
223 ([M]+, 25%), 163 (44%), 135 (61%), 121 (100%), 105 (14%), 91 (32%), 77 (16%), 
65 (10%). 
 
 3-(4-fluorophenyl)-N-methoxy-N-methylpropanamide 
(167) (2.46 g, 66%) was prepared according to the 
representative procedure from 3-(4-fluorophenyl)propanoyl chloride (3.50 g, 18.75 
mmol) giving the pure Weinreb amide as a colorless oil.   1H NMR (CDCl3, 400 MHz) δ 
ppm 2.70 (apparent triplet, J=7.30 Hz, 2 H) 2.92 (apparent triplet, J=8.60 Hz, 2 H) 3.16 
(s, 3 H) 3.59 (s, 3 H) 6.95 (t, J=8.68 Hz, 2 H) 7.17 (dd, J=8.31, 5.62 Hz, 2 H) 13C NMR 
(CDCl3, 100 MHz) δ ppm 30.02 (CH2) 32.39 (CH3) 33.98 (CH2) 61.41 (CH3) 115.36 (d, 
JC-C-F =20.54 Hz, CH) 130.06 (d, JC-C-C-F =8.07 Hz, CH) 137.18 (d, JC-C-C-C-F =3.67 Hz, C) 
161.60 (d, JC-F J=243.55 Hz, C-F) 173.66 (C) 19F  NMR (CDCl3, 377 MHz) δ ppm -
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119.41 - -119.31 (m, 160 F) -82.35 (s, 202 F) GC-MS (EI) 211 ([M]+, 14%), 151 (8%), 
123 (36%), 109 (100%), 103 (14%), 83 (9%), 75 (6%), 61 (18%), 57 (3%). HRMS (ESI+), 
calcd for C11H14FNO2  [M+H]+ 212.1087 found: 212.1099  
 
 N-methoxy-3-(p-tolyl)-N-methylpropanamide (168)  (3.94 g, 
62%) was prepared according to the representative procedure 
from 3-(p-tolyl)propanoyl chloride (5.60 g, 30.7 mmol) giving the pure Weinreb amide as 
a colorless oil.   1H NMR (CDCl3, 400 MHz) δ ppm 2.32 (s, 3 H) 2.73 (apparent triplet, 
J=7.60 Hz, 2 H) 2.93 (apparent triplet, J=8.10 Hz, 2 H) 3.18 (s, 3 H) 3.61 (s, 3 H) 6.97 - 
7.21 (m, 4 H) 13C NMR (CDCl3, 100 MHz) δ ppm 21.26 (CH3) 30.51 (CH2) 32.44 (CH3) 
34.20 (CH2) 61.46 (CH3) 128.56 (CH) 129.39 (CH) 135.82 (C) 138.51 (C) 174.08 (C)  
GC-MS (EI) 207 ([M]+, 15%), 147 (11%), 119 (29%), 105 (100%), 91 (16%), 77 (12%), 
65 (6%), 61 (9%), 39 (3%). HRMS (ESI+), calcd for C12H17NO2  [M+H]+ 208.1338, found: 
208.1343 
 
 N-methoxy-3-(4-methoxyphenyl)-N-methylpropanamide10 (169)  (5.11 g, 61%) was 
prepared according to the representative procedure from 3-
(4-methoxyphenyl)propanoyl chloride (7.45 g, 37.5 mmol) 
giving the pure Weinreb amide as a colorless oil.   1H NMR (CDCl3, 400 MHz) δ ppm 
2.70 (apparent triplet, J=7.80 Hz, 2 H) 2.89 (apparent triplet, J=8.10 Hz, 2 H) 3.16 (s, 3 
H) 3.59 (s, 3 H) 3.77 (s, 3 H) 6.82 (d, J=8.07 Hz, 2 H) 7.14 (d, J=8.31 Hz, 2 H) 13C NMR 
(CDCl3, 100 MHz) δ ppm 30.01 (CH2) 32.38 (CH3) 34.22 (CH2) 55.45 (CH3) 61.41 (CH3) 
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114.06 (CH) 129.57 (CH) 133.60 (C) 158.16 (C) 174.01 (C) GC-MS (EI) 223 ([M]+, 8%), 
192(4%), 163 (4%), 135 (7%), 121 (100%), 105 (3%), 91 (11%), 77 (8%), 65 (4%). 
 
N-methoxy-N-methyl-3-phenylpropanamide10 (170) (10.74 g, 
93%) was prepared according to the representative procedure 
from 3-phenylpropanoyl chloride (10.1172 g, 60 mmol) giving the pure Weinreb amide 
as a yellow oil.  1H NMR (CDCl3, 400 MHz) δ ppm 2.77 (t, J=7.60 Hz, 12 H) 2.99 (t, 
J=8.30 Hz,  2 H) 3.20 (s, 3 H) 3.61 (s, 3 H) 7.04 - 7.47 (m, 5 H) 13C NMR (CDCl3, 100 
MHz) δ ppm 30.50 (CH2) 31.92 (CH3) 33.56 (CH2) 60.93 (CH3) 125.91 (CH) 128.25 (2 x 
CH) 141.17 (C) 173.35 (C) GC-MS (EI) 193 ([M]+, 24%), 133 (20%), 105 (100%), 103 
(16%), 91 (95%), 77 (24%), 65 (12%), 61 (18%), 51 (11%), 39 (5%). 
 
 N-methoxy-N-methylnaphthalene-1-carboxamide5 (149) (8.17 g, 
95%) was prepared according to the representative procedure from 
naphthalene-1-carbonyl chloride (7.625 g, 40 mmol) giving the pure 
Weinreb amide as a white solid.  1H NMR (CDCl3, 400 MHz) δ ppm 2.81 - 3.78 
(overlapping s br, 6 H) 7.44 - 7.57 (m, 4 H) 7.82 - 7.95 (m, 3 H) 13C NMR (CDCl3, 100 
MHz) δ ppm  33.06 (CH3) 61.06 (CH3) 124.13 (CH) 124.64 (CH) 124.74 (CH) 126.11 
(CH) 126.71 (CH) 128.17 (CH) 129.39 (CH) 129.55 (C) 133.05 (C) 133.15 (C) 169.70 
(C) GC-MS (EI) 215 ([M]+, 3%), 155 (100%), 127 (84%), 101 (5%), 77 (9%), 44 (8%). 
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5-bromo-N-methoxy-N-methylthiophene-2-carboxamide (171) 
(4.77 g, 38% over two steps1) was prepared according to the 
representative procedure from 5-bromothiophene-2-carboxylic acid (50 mmol) giving the 
pure Weinreb amide as a yellow oil.   1H NMR (CDCl3, 500 MHz) δ ppm 3.25 (s, 3 H) 
3.68 (s, 3 H) 6.99 (d, J=4.21 Hz, 1 H) 7.63 (d, J=4.21 Hz, 1 H) 13C NMR (CDCl3, 125 
MHz) δ ppm 32.86 (CH3) 61.69 (CH3) 120.55 (C) 129.73 (CH) 133.53 (C) 134.64 (CH) 
160.98 (C) GC-MS (EI) 251 ([M]+1, 9%), 250 ([M]+, 1%), 191 (100%), 189 (98%), 119 
(7%), 117 (7%), 82 (28%), 44 (5%). HRMS (ESI+), calcd for C7H8BrNO2S  [M + H]+ 
249.9537, found: 249.9528 
 
N,3,5-trimethoxy-N-methylbenzamide11  (172) (3.84 g, 69%) 
was prepared according to the representative procedure from 
3,5-dimethoxybenzoyl chloride (5.016 g, 25 mmol) giving the 
pure Weinreb amide as a yellow oil.   1H NMR (CDCl3, 500 MHz) δ ppm 3.28 (s, 1 H) 
3.54 (s, 3 H) 3.75 (s, 3 H) 6.49 (s, 1 H) 6.74 (s, 2 H) 13C NMR (CDCl3, 125 MHz) δ ppm 
34.14 (CH3) 55.60 (CH3) 61.26 (CH3) 102.87 (CH) 106.04 (CH) 136.16 (C) 160.52 (C) 
169.73 (C) GC-MS (EI) 225 ([M]+, 9%), 165 (100%), 137 (27%), 122 (24%), 107 (11%), 
79 (6%), 77 (8%). 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Note that in the case of this substrate the acid chloride was prepared in situ in the 
reaction flask just prior to use. 
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N-methoxy-N-methyloctanamide12 (97) (7.22 g, 96%) was 
prepared according to the representative procedure from 
octanoyl chloride (6.506 g, 40 mmol) giving the pure Weinreb amide as a colorless oil.   
1H NMR (CDCl3, 500 MHz) δ ppm 0.81 (t, J=6.90 Hz, 3 H) 1.16 - 1.32 (m, 8 H) 1.56 
(quin, J=7.25 Hz, 2 H) 2.35 (t, J=7.25 Hz, 2 H) 3.11 (s, 3 H) 3.62 (s, 3 H) 13C NMR 
(CDCl3, 100 MHz) δ ppm  14.07 (CH3) 22.63 (CH2) 24.67 (CH2) 29.11 (CH2) 29.42 (CH2) 
31.74 (CH2) 31.90 (CH2) 32.12 (CH3) 61.16 (CH3) 174.76 (C)  GC-MS (EI) 187 ([M]+, 
1%), 127 (60%), 109 (7%), 103 (11%), 61 (53%), 57 (100%), 55 (18%), 43 (25%), 41 
(21%).  
 
2-ethyl-N-methoxy-N-methylhexanamide13 (132) (7.14 g, 95%) 
was prepared according to the representative procedure from 2-
ethylhexanoyl chloride (6.51 g, 40 mmol) giving the pure Weinreb amide as a colorless 
oil.   1H NMR (CDCl3, 500 MHz) δ ppm 0.83 (t, J=7.80 Hz, 6 H) 1.13 - 1.33 (m, 4 H) 1.33 
- 1.51 (m, 2 H) 1.53 - 1.66 (m, 2 H) 2.62 - 2.82 (broad s, 1 H) 3.16 (s, 3 H) 3.64 (s, 3 H)  
13C NMR (CDCl3, 125 MHz) δ ppm 12.29 (CH3) 14.15 (CH3) 23.05 (CH2) 25.88 (CH2) 
30.09 (CH2) 32.37 (CH2) 42.58 (CH3) 47.23 (CH) 61.55 (CH3) 178.20 (C) GC-MS (EI) 
187 ([M]+, .01%), 127 (21%), 99 (12%), 57 (100%), 55 (15%), 43 (15%), 40 (54%).  
 
2-cyclohexyl-N-methoxy-N-methylacetamide 14  (173) (6.40 g, 
86%) was prepared according to the representative procedure from 
2-cyclohexylethanoyl chloride (6.426 g, 40 mmol) giving the 
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Weinreb amide as a colorless oil.   1H NMR (CDCl3, 500 MHz) δ ppm 0.87 (qd, J=12.19, 
3.15 Hz, 2 H) 1.05 (apparent q, 1 H) 1.19 (apparent q, 2 H) 1.53 - 1.69 (m, 5 H) 1.69 - 
1.81 (m, 1 H) 2.20 (d, J=6.94 Hz, 2 H) 3.08 (s, 3 H) 3.58 (s, 3 H) 13C NMR (CDCl3, 100 
MHz) δ ppm 26.18 (CH2) 26.32 (CH2) 32.05 (CH3) 33.39 (CH2) 34.52 (CH2) 39.36 (CH) 
61.18 (CH3) 174.04 (C) GC-MS (EI) 185 ([M]+, 2%), 125 (76%), 103 (22%), 97 (98%), 
83 (22%), 73 (13%), 61 (35%), 55 (100%), 41 (24%), 39 (12%). 
 
N-methoxy-N-methyl-2-phenylacetamide15  (130) (6.25 g, 87%) 
was prepared according to the representative procedure from 2-
phenylacetyl chloride  (6.184 g, 40 mmol) giving the pure Weinreb amide as a yellow oil.   
1H NMR (CDCl3, 500 MHz) δ ppm 3.14 (s, 3 H) 3.55 (s, 3 H) 3.73 (s, 2 H) 7.17 - 7.22 (m, 
1 H) 7.24 - 7.31 (m, 4 H) 13C NMR (CDCl3, 125 MHz) δ ppm  32.30 (CH3) 39.46 (CH2) 
61.34 (CH3) 126.84 (CH) 128.56 (CH) 129.38 (CH) 135.05 (C) 172.53(C) GC-MS (EI) 
179 ([M]+, 3%), 119 (4%), 118 (32%), 91 (100%), 65 (14%), 61 (10%), 40 (28%).   
 
N-methoxy-N,2-dimethyl-2-phenylpropanamide (131) (7.03 g, 
88%) was prepared according to the representative procedure from 
2-methyl-2-phenylpropanoyl chloride (7.08 g, 39 mmol) giving the pure Weinreb amide 
as a yellow oil.   1H NMR (CDCl3, 500 MHz) δ ppm 1.54 (s, 6 H) 2.64 (s, 3 H) 3.09 (s, 3 
H) 7.19 (apparent  tt, J=7.20, 1.30 Hz, 1 H) 7.25 - 7.28 (m, 2 H) 7.29 - 7.34 (m, 2 H)  13C 
NMR (CDCl3, 125 MHz) δ ppm 26.81 (CH3) 33.60 (CH2) 47.01 (C) 59.08 (CH3) 125.72 
(CH) 126.26 (CH) 128.46 (C) 146.28 (C) 177.91 (C)  GC-MS (EI) 207 ([M]+, 3%), 147 
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(8%), 119 (100%), 103 (8%), 91 (43%), 77 (10%), 40 (12%). HRMS (ESI+), calcd for 
C12H17NO2 [M+H]+ 208.1338, found: 208.1334  
  
 N-methoxy-N-methylcinnamide 16  (146) (3.46 g, 91%) was 
prepared according to the representative procedure from trans-
cinnamoyl chloride (3.332 g, 20 mmol) giving the pure Weinreb amide as a white solid.   
1H NMR (CDCl3, 400 MHz) δ ppm 3.31 (s, 3 H) 3.77 (s, 3 H) 7.04 (d, J=15.89 Hz, 1 H) 
7.35 - 7.40 (m, 3 H) 7.57 (apparent d, J=7.58 Hz, 2 H) 7.74 (d, J=15.89 Hz, 1 H) 13C 
NMR (CDCl3, 100 MHz) δ ppm 32.79 (CH3) 62.16 (CH3) 116.06 (CH) 128.32 (CH) 
129.07 (CH) 130.11 (CH) 135.45 (C) 143.73 (CH) 167.24 (C) GC-MS (EI) 191 ([M]+, 
5%), 131 (100%), 103 (47%), 77 (27%), 51 (10%), 44 (42%), 40 (4%). 
 
 (E)-N-methoxy-3-(4-methoxyphenyl)-N-methylacrylamide17 (174) (1.90 g, 86%) was 
prepared according to the representative procedure from 4-
methoxycinnamoyl chloride (1.966 g, 10 mmol) giving the 
Weinreb amide as a colorless oil.   1H NMR (CDCl3, 400 
MHz) δ ppm 3.24 (s, 3 H) 3.69 (s, 3 H) 3.75 (s, 3 H) 6.80 - 6.89 (m, 3 H) 7.46 (d, J=8.80 
Hz, 2 H) 7.64 (d, J=15.65 Hz, 1 H) 13C NMR (CDCl3, 100 MHz) δ ppm 32.55 (CH3) 
55.37 (CH3) 61.85 (CH3) 113.40 (CH) 114.28 (CH) 127.91 (C) 129.69 (CH) 143.09 (CH) 
161.10 (C) 167.37 (C) GC-MS (EI) 221 ([M]+, 3%), 161 (100%), 133 (20%), 118 (8%), 
103 (4%), 89 (8%), 77 (6%). 
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 (E)-3-(4-fluorophenyl)-N-methoxy-N-methylacrylamide 18 
(175) (4.06 g, 65%) was prepared according to the 
representative procedure from 4-fluorocinnamoyl chloride  (5.538 g, 30 mmol) giving the 
pure Weinreb amide as a white solid.   1H NMR (CDCl3, 500 MHz) δ ppm 3.27 (s, 3 H) 
3.73 (s, 3 H) 6.93 (d, J=15.76 Hz, 1 H) 7.03 (t, J=8.51 Hz, 2 H) 7.47 - 7.56 (m, 2 H) 7.66 
(d, J=15.76 Hz, 1 H) 13C NMR (CDCl3, 125 MHz) δ ppm 32.66 (CH3) 62.05 (CH3) 115.73 
(CH) 116.04 (d, JC-C-F = 21.08 Hz, CH) 130.03 (d, JC-C-C-F = 8.20 Hz, CH) 131.58 (d, JC-C-
C-C-F =3.70 Hz, C) 142.29 (CH) 163.79 (d, JC- F = 250.20 Hz, C-F) 166.96 (C) 19F  NMR 
(CDCl3, 377 MHz)  -113.64 GC-MS (EI) 209 ([M]+, 2%), 207 (9%), 149 (100%), 121 
(35%), 101 (30%), 95 (5%), 75 (10%), 44 (23%). 
 
  (E)-3-(furan-2-yl)-N-methoxy-N-methylprop-2-enamide 19 
(176) (1.15 g, 80%) was prepared according to the 
representative procedure from (E)-3-(furan-2-yl)prop-2-enoyl chloride (1.266 g, 8 mmol) 
giving the pure Weinreb amide as a brown oil.   1H NMR (CDCl3, 400 MHz) δ ppm  3.22 
(s, 3 H) 3.69 (s, 3 H) 6.46 (apparent doublet, J=54.30 Hz, 2 H) 6.86 (apparent d, 
J=15.41 Hz, 1 H) 7.35 - 7.50 (m, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 32.61 (CH3) 
61.98 (CH3) 112.32 (CH) 113.72 (CH) 114.39 (CH) 129.96 (CH) 144.26 (CH) 151.76 (C) 
167.05 (C) GC-MS (EI) 181 ([M]+, 7%), 121 (100%), 93 (4%), 65 (24%), 63 (4%), 39 
(9%). 
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 (E)-N-methoxy-N-methyldec-2-enamide 20  (133) 
(6.94 g, 82%) was prepared according to the 
representative procedure from (E)-dec-2-enoyl chloride (7.54 g, 40 mmol) giving the 
pure Weinreb amide as a yellow oil.   1H NMR (CDCl3, 500 MHz) δ ppm 0.87 (t, J=6.94 
Hz, 3 H) 1.21 - 1.32 (m, 8 H) 1.46 (quin, J=6.90 Hz, 2 H) 2.22 (q, J=7.15 Hz, 2 H) 3.23 
(s, 3 H) 3.69 (s, 3 H) 6.38 (d, J=15.13 Hz, 1 H) 6.97 (dt, J=15.76, 6.90 Hz, 1 H)  13C 
NMR (CDCl3, 125 MHz) δ ppm 14.24 (CH3) 22.81 (CH2) 28.50 (CH2) 29.25 (CH2) 29.33 
(CH2) 31.95 (CH2) 32.56 (CH3) 32.69 (CH2) 61.81 (CH3) 118.78 (CH) 148.27 (CH) 
167.34 (C)  GC-MS (EI) 213 ([M]+, 3%), 153 (100%), 83 (24%), 81 (15%), 69 (47%), 55 
(82%), 43 (16%), 41 (23%).    
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General Procedure B: Weinreb Amides from Carboxylic Acid via CDI Activation:21  
 
 
N-methoxy-N,3,7-trimethyloct-6-enamide21 (178) 
 
To a 250 mL round bottom flask equipped with stir bar was added (±)-citronellic acid 
(4.01 g, 23.5 mmol, 1 equiv.) and DCM (80 mL ≈ 0.3M). To this stirred solution was 
added 1,1ʼ-carbonyl diimidazole (4.19 g, 25.8 mmol, 1.1 equiv.) in one portion, turning 
the solution yellow and resulting in the evolution of CO2 gas. The now yellow solution 
was allowed to stir for 45 minutes. At this time, N-O-dimethylhydroxylamine 
hydrochloride (2.52 g, 25.8 mmol, 1.1 equiv.) was added all at once and the reaction 
mixture was stirred overnight. The reaction mixture was then quenched with 30 mL of 1 
M HCl and stirred vigorously for 10 minutes. After this time, the solution was transferred 
to a separatory funnel and the layers were separated. The aqueous layer was extracted 
with DCM (2 X 100 mL). The combine organic layers were washed with 1 M HCl (50 
mL), deionized water (50 mL) and a 1:1 mixture of brine and a saturated sodium 
bicarbonate solution (100 mL). The organic layer was dried with Na2SO4 and the solvent 
was removed in vacuo by rotary evaporation  to afford the pure amide (3.98 g, 79.4%).  
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1H NMR (CDCl3, 400 MHz) δ ppm 0.90 (d, J=6.60 Hz, 3 H) 1.09 - 1.23 (m, 1 H) 1.29 - 
1.40 (m, 1 H) 1.55 (s, 3 H) 1.63 (s, 3 H) 1.86 - 2.05 (m, 3 H) 2.15 - 2.29 (m, 1 H) 2.29 - 
2.44 (m, 1 H) 3.14 (s, 3 H) 3.63 (s, 3 H) 5.06 (t, J=6.97 Hz, 1 H)  13C NMR (CDCl3, 100 
MHz) δ ppm 17.81 (CH3) 19.99 (CH2) 25.73 (CH2) 25.88 (CH3) 29.73 (CH) 32.27 (CH3) 
37.30 (CH2) 39.29 (CH2) 61.33 (CH3) 124.70 (CH) 131.44 (C) 174.51 (C) GC-MS (EI) 
213 ([M]+, 1%), 153 (35%), 135 (6%), 130 (6%), 109 (62%), 83 (16%), 81 (18%), 73 
(10%), 69 (100%), 67 (17%), 61  (62%), 55 (24%), 43 (14%), 41 (43%).   
 
 3-(furan-2-yl)-N-methoxy-N-methylpropanamide (179) (3.40 g, 
79%) was prepared according to the representative procedure 
from 3-(furan-2-yl)propanoic acid22 (3.29g, 23.5 mmol) giving the pure Weinreb amide 
as a clear light brown oil. 1H NMR (CDCl3, 400 MHz) δ ppm 2.77 (t, J=7.60 Hz, 2 H) 2.98 
(t, J=8.30 Hz, 2 H) 3.18 (s, 3 H) 3.65 (s, 3 H) 6.03 (apparent dd, J=2.20, 1.00 Hz, 1 H) 
6.27 (dd, J=3.18, 1.96 Hz, 1 H) 7.30 (dd, J=1.83, 0.86 Hz, 1 H)  13C NMR (CDCl3, 100 
MHz) δ ppm 23.21 (CH2) 30.55 (CH2) 32.35 (CH3) 61.38 (CH3) 105.38 (CH) 110.36 
(CH) 141.18 (CH) 155.03 (C) 173.35 (C) GC-MS (EI) 183 ([M]+, 20%), 123 (13%), 94 
(12%), 81 (100%), 67 (10%), 61 (19%), 53 (10%). HRMS (ESI+), calcd for C9H13NO3  [M 
+ H]+ 184.0973, found: 184.0975.	   
 
 N-methoxy-N-methylisonicotinamide23 (180) (5.23 g, 78%) was 
prepared according to the representative procedure from isonicotinic 
acid (4.924 g, 40 mmol) with the following modifications24:  
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a) The reaction was stirred for 150 min; b) After the reaction was complete, the reaction 
was quenched with 225 mL of a ≈ 1 M NaOH solution. The aqueous layer was extracted 
with DCM (2 X 200 mL) washed with brine (1 X 100 mL), dried with Na2SO4 and the 
solvent was removed in vacuo via rotary evaporation to give the pure Weinreb amide as 
a yellow oil.   1H NMR (CDCl3, 400 MHz) δ ppm 3.13 (s, 3 H) 3.32 (s, 3 H) 7.30 (d, 
J=4.65 Hz, 2 H) 8.48 (d, J=4.65 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 32.83 
(CH3) 61.11 (CH3) 121.69 (CH) 141.48 (C) 149.63 (CH) 167.24 (C) GC-MS (EI) 166 
([M]+, 5%), 135 (12%), 106 (100%), 78 (71%), 51 (31%), 50 (11%). 
  
 
 5-bromo-N-methoxy-N-methylfuran-2-carboxamide 25  (181) 
(5.70 g, 70%) was prepared according to the representative 
procedure from 5-bromo-2-furanoic acid (6.69 g, 35 mmol) with the following 
modifications: a) The reaction was worked up six hours after addition of the N-O-
dimethylhydroxylamine hydrochloride. The pure Weinreb amide  was obtained as a 
clear yellow oil   1H NMR (CDCl3, 400 MHz) δ ppm 3.17 (s, 3 H) 3.62 (s, 3 H) 6.32 (d, 
J=3.42 Hz, 1 H) 6.94 (d, J=3.67 Hz, 1 H) 13C NMR (CDCl3, 100 MHz) δ ppm 32.98 (CH3) 
61.34 (CH3) 113.54 (CH) 119.64 (CH) 126.31 (C) 147.57 (C) 157.75 (C)  GC-MS (EI) 
235 ([M]+, 81Br  7%), 233([M]+, 79Br  7%), 175 (81Br  98%), 173 (79Br  100%), 119 (81Br 
24%), 117 (79Br  24%) 66 (16%) 38 (19%). 
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General Procedure for Trifluoromethyl Ketone Synthesis: 
 
 
 General Procedure A: Small Scale Synthesis of TFMKs:	   
 
1-(4-(t-butyl)phenyl)-2,2,2-trifluoroethanone26 (96) 
 
To a 50 mL round bottom flask equipped with a stir bar was added CsF (0.1512 g, 1.0 
mmol, 0.2 equiv.). Toluene (2.5 mL) was added to the flask, followed by 4-(tert-butyl)-N-
methoxy-N-methylbenzamide (1.11 g, 5.0 mmol, 1 equiv.) (94). The flask was sealed 
with a septum equipped with a inlet needle as an exit valve. The flask was cooled to 0 
oC for 10 minutes.  Once cooled, TMS-CF3 (1.42 g, 10.0 mmol, 2 equiv.) was added to 
the reaction mixture drop wise over a period of ≈ 10 minutes. After completion of 
addition, the reaction mixture was allowed to stir at 0 oC for 10 minutes. The cooling 
bath was removed and the reaction mixture was allowed to stir at room temperature. 
CAUTION: Upon reaching room temperature, the reaction occurs and is mildly 
exothermic and gas is evolved. After completion of addition, the reaction mixture was 
allowed to stir at room temperature overnight. Reaction progress was monitored by 1H 
N
O
OMe TMS-CF3
20 mol% CsF.
Toluene, 0 oC-rt, 24 h
N OMe
F3C OTMS TBAF
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NMR2. Note: Over this time period the solution became dark yellow to dark brown in 
color.  
 
Once complete conversion to the silylated intermediate was confirmed, water (5 
mL) followed by TBAF (5 mL, 1 M in THF, 1 equiv.) were added to the reaction flask. 
The flask was equipped with a reflux condenser, open to air. The contents were then 
heated to 50 oC by either conventional or microwave methods, and allowed to stir at that 
temperature for 2 hours. Once cooled to room temperature, the reaction mixture were 
diluted with Et2O (≈ 30 mL), and transferred to a separatory funnel. The organic layer 
was washed with deionized water (3 X 30 mL), followed with a brine solution (1 X 30 
mL). The organic layer was dried with Na2SO4 and the solvent was removed in vacuo by 
rotary evaporation to yield crude trifluoromethyl ketone. Further purification was 
accomplished by flash chromatography (8:2 Hex:EtOAc) produced the pure CF3 ketone 
as an orange solid (0.935 g, 81%). 1H NMR (CDCl3, 400 MHz) δ ppm 1.36 (s, 9 H) 7.56 
(d, J=8.80 Hz, 2 H) 8.02 (d, J=8.07 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm  31.15 
(CH3) 35.73 (C) 117.10 (q, JC-C-F = 289.80 Hz, CF3) 126.42 (CH) 127.64 (C) 130.45 (q, 
JC-C-C-C-F = 2.20 Hz, CH) 160.13 (C) 180.37 (q, JC-C-F = 34.50 Hz, C) 19F  NMR (CDCl3, 
377 MHz) δ ppm -74.73. GC-MS (EI) 230 ([M]+, 15%), 215 (100%), 187 (32%), 161 
(56%), 159 (11%), 146 (10%), 118 (24%), 115 (14%), 91 (12%), 77 (8%), 69 (3%), 57 
(3%). 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 Most, if not all, substrates converted near quantitatively after stirring for 24 h. 
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Synthesis of TFMK Procedure B (Large Scale): 
 
1,1,1-trifluoro-4-phenylbutan-2-one27 (110)	   
 
To a 250 mL round bottom flask equipped with a stir bar was added CsF (0.820 g, 5.4 
mmol, 0.2 equiv.). Toluene (54 mL, 0.5 M in the Weinreb amide) was added to the flask, 
followed by N-methoxy-N-methyl-3-phenylpropanamide (5.30 g, 27 mmol, 1 equiv.) 
(171). The flask was sealed with a septum equipped with a inlet needle as an exit valve. 
The flask was cooled to 0 oC for 10 minutes.   TMS-CF3 (7.82 g, 55 mmol, 2 equiv.) was 
added to the reaction mixture drop wise over a period of ≈ 10 minutes. After completion 
of addition, the reaction mixture was allowed to stir for 10 minutes. The cooling bath was 
removed and the reaction mixture was allowed to stir at room temperature. CAUTION: 
Upon reaching room temperature, the reaction occurs and is mildly exothermic and gas 
is evolved. After completion of addition, the reaction mixture was allowed to stir at room 
temperature overnight. Reaction progress was monitored by 1H NMR3. Note: Over this 
time period the solution became dark yellow to dark brown in color. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Most, if not all, substrates converted near quantitatively after stirring for 24 h. 
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Once complete conversion to the silylated intermediate was confirmed, the 
toluene was removed in vacuo by rotary evaporation. Hexanes (20 mL), followed by 
Water (27 mL) followed by 1M solution of TBAF in THF (27 mL, 27 mmol, 1 equiv.) were 
added to the reaction flask. The flask was equipped with a reflux condenser, open to air. 
The reaction mixture was then heated to 50 oC in an oil bath and allowed to stir 2 hours. 
Once cooled to room temperature, the reaction mixture were diluted with Et2O (≈ 120 
mL), and transferred to a separatory funnel. The organic layer was washed with 
deionized water (3 X 120 mL), followed with a brine solution (1 X 120 mL). The organic 
layer was dried with Na2SO4 and the solvent was removed in vacuo by rotary 
evaporation to yield crude trifluoromethyl ketone. Further purification was accomplished 
Vacuum distillation (b.p. 77-80 oC @ 6 mmHg) afforded the pure CF3 ketone as a clear 
colorless oil (4.16 g, 76%). 1H NMR (CDCl3, 400 MHz) δ ppm 2.99 - 3.23 (m, 4 H) 7.28 - 
7.38 (m, 3 H) 7.38 - 7.48 (m, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 28.49 (CH2) 38.24 
(CH2) 115.83 (q, JC-F = 292.00 Hz, CF3) 126.89 (CH) 128.50 (CH) 128.94 (CH) 139.55 
(C) 190.87 (q, JC-C-F = 35.20 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -82.01 GC-MS 
(EI) 202 ([M]+, 38%), 133 (42%), 105 (37%), 103 (11%), 91 (100%), 77 (17%), 69 (6%), 
65 (12%), 51 (11%), 39 (5%). 
 
 N-(1-(4-(tert-butyl)phenyl)-2,2,2-trifluoro-1-((trimethylsilyl)oxy)ethyl)-N,O-
dimethylhydroxylamine (183) (1.56 g, 86%) was prepared 
according to the representative procedure A from 4-(tert-butyl)-N-
methoxy-N-methylbenzamide (1.11 g, 5 mmol) (94) with the 
N OMe
F3C OTMS
183
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following modifications: prior to the cleavage step the contents were filtered and the 
toluene removed in vacuo  to produce the intermediate as a brown oil.   1H NMR (CDCl3, 
300 MHz) δ ppm 0.30 (s, 9 H) 1.34 (s, 9 H) 2.32 (s, 3 H) 3.60 (s, 3 H) 7.37 (d, J=8.48 
Hz, 2 H) 7.55 (d, J=8.48 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 2.27 (CH3) 31.61 
(CH3) 34.82 (C) 36.94 (q, JC-N-C-C-F = 1.50 Hz, CH3) 59.66 (CH3) 93.49 (q, JC-C-F = 29.30 
Hz, C) 123.99 (q, JC-F =291.20 Hz, CF3) 125.11 (CH) 127.54 (CH 134.86 (C) 152.09 (C) 
19F  NMR (CDCl3, 377 MHz) δ ppm -76.60 GC-MS (EI) 303 ([M]-60, 39%), 174 (5%), 161 
(100%), 73 (23%). HRMS (ESI+), calcd for C17H28F3NO2Si [M- C2H6NO]+ 303.1392, 
found: 303.1409.	   
 
  2,2,2-trifluoro-1-(3-nitrophenyl)ethanone28 (101) (0.865 g, 78%) was 
prepared according to the representative procedure A from N-methoxy-
N-methyl-3-nitrobenzamide (1.05 g, 5 mmol) (161). Flash 
chromatography on deactivated silica (8:2 hexanes/EtOAc, 10% NEt3) afforded the pure 
CF3 ketone as a yellow solid.   1H NMR (CDCl3, 400 MHz) δ ppm 7.82 (t, J=8.07 Hz, 1 
H) 8.40 (d, J=7.82 Hz, 1 H) 8.57 (dd, J=8.19, 0.86 Hz, 1 H) 8.88 (s, 1 H) 13C NMR 
(CDCl3, 100 MHz) δ ppm 116.47 (q, JC-F = 287.60 Hz, 6 CF3) 125.11 (m, CH) 129.86 
(CH) 130.90 (CH) 131.33 (C) 135.54 (CH) 148.85 (C) 179.09 (q, JC-C-F = 35.90 Hz, C) 
19F  NMR (CDCl3, 377 MHz) δ ppm -74.89 GC-MS (EI) 150 (100%), 123 (10%), 104 
(36%), 95 (10%), 76 (31%), 69 (5%), 50 (12%). 
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 1-(3-bromophenyl)-2,2,2-trifluoroethanone 29  (102) (0.908 g, 72%) 
was prepared according to the representative procedure A from 3-
bromo-N-methoxy-N-methylbenzamide (1.220 g, 5 mmol) (162). Flash 
chromatography (8:2 Hex/EtOAc) afforded the pure CF3 ketone as a yellow oil.   1H 
NMR (CDCl3, 400 MHz) δ ppm 7.45 (t, J=7.95 Hz, 1 H) 7.85 (d, J=9.05 Hz, 1 H) 8.01 (s, 
1 H) 8.20 (s, 1 H) 13C NMR (CDCl3, 100 MHz) δ ppm 116.65 (q, JC-F =291.20 Hz, CF3) 
123.64 (C) 128.79 (CH) 130.88 (CH) 131.81 (C) 133.08 (CH) 138.66 (CH) 179.60 (q, JC-
C-F 35.90 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -74.59 GC-MS (EI) 254 ([M]+2, 24%), 
252 ([M]+, 25%), 185 (97%), 183 (100%), 157 (61%), 155 (63%), 76 (37%), 75 (34%), 
74 (20%), 69 (9%), 50 (26%). 
 
 2,2,2-trifluoro-1-(4-methoxyphenyl)ethanone 30  (103) (0.90 g, 
88%) was prepared according to the representative procedure A 
from N,4-dimethoxy-N-methylbenzamide (0.976 g, 5 mmol) (163). 
Flash chromatography (8:2 Hex/ EtOAc) afforded the pure CF3 ketone  as a yellow oil.   
1H NMR (CDCl3, 400 MHz) δ ppm 3.89 (s, 3 H) 6.98 (dd, J=9.05, 2.45 Hz, 2 H) 8.02 (d, 
J=8.07 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 55.84 (CH3) 114.68 (CH) 117.21 (q, 
JC-C-F =291.20 Hz, CF3) 122.98 (C) 132.95 (CH) 165.73 (C) 179.13 (q, JC-C-F = 34.50 Hz, 
C) 19F  NMR (CDCl3, 377 MHz) δ ppm  -73.82  GC-MS (EI) 204 ([M]+, 21%), 135 (100%), 
107 (13%), 92 (24%), 77 (29%), 69 (4%), 64 (11%). 
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 1,1,1-trifluoro-4-(2-methoxyphenyl)butan-2-one (104) (3.46 g, 
75%) was prepared according to the representative procedure B 
from N-methoxy-3-(2-methoxyphenyl)-N-methylpropanamide  (4.425 g, 20 mmol) (164). 
Vacuum distillation (b.p. 56-57 oC @ 0.3 mmHg) afforded the pure CF3 ketone as a 
clear colorless oil.   1H NMR (CDCl3, 400 MHz) δ ppm 2.74 - 3.22 (m, 4 H) 3.83 (s, 3 H) 
6.85-6.91 (m, 2H) 7.15 (d, J=7.34 Hz, 1 H) 7.23 (t, J=7.30 Hz, 1 H) 13C NMR (CDCl3, 
100 MHz) δ ppm 24.27 (CH2) 36.75 (CH2) 55.29 (CH3) 110.53 (CH) 115.88 (q, JC-F = 
292.00 Hz, CF3) 120.82 (CH) 127.79 (C) 128.33 (CH) 130.37 (CH) 157.68 (C) 191.42 (q, 
JC-C-F =35.20 Hz, C) 19F NMR (CDCl3, 377 MHz) δ ppm -82.11 GC-MS (EI) 232 ([M]+, 
51%), 163 (9%), 121 (100%), 108 (12%), 91 (100%), 77 (13%), 69 (4%), 65 (13%), 51 
(7%). HRMS (ESI+), calcd for C11H11F3O2 [M+H]+ 233.0789, found: 233.0777  
 
 1,1,1-trifluoro-4-(o-tolyl)butan-2-one (105) (1.51 g, 66%) was 
prepared according to the representative procedure B from N-
methoxy-3-(o-tolyl)-N-methylpropanamide  (2.2 g, 10.62  mmol) (165) giving the pure 
Weinreb amide as a colorless oil. Vacuum distillation (b.p. 74-76 oC @ 2.5 mmHg) 
afforded the pure CF3 ketone as a clear colorless oil.   1H NMR (CDCl3, 500 MHz) δ 
ppm 2.36 (s, 3 H) 2.83 - 3.14 (m, 4 H) 7.14 - 7.23 (m, 4 H) 13C NMR (CDCl3, 125 MHz) 
δ ppm 19.45 (CH3) 25.97 (CH2) 37.06 (CH2) 115.85 (q, JC-F =292.30 Hz, CF3) 126.62 
(CH) 127.12 (CH) 128.76 (CH) 130.80 (CH) 136.15 (C) 137.62 (C) 191.02 (q, JC-C-F 
=34.80 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -82.24 GC-MS (EI) 216 ([M]+, 30%), 
CF3
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147 (19%), 129 (17%), 119 (13%), 105 (100%), 91 (21%), 77 (17%), 69 (8%), 65 (8%). 
HRMS (ESI+), calcd for C11H11F3O  [M + H – H2O]+ 199.0735, found:199.0730 
 
 1,1,1-trifluoro-4-(3-methoxyphenyl)butan-2-one(106) (6.07 g, 
81%) was prepared according to the representative procedure B 
from N-methoxy-3-(3-methoxyphenyl)-N-methylpropanamide  (7.20 
g, 32.24 mmol) (166). Vacuum distillation (b.p. 56-59 oC @ 0.1 mmHg) afforded the 
pure CF3 ketone as a clear colorless oil.  1H NMR (CDCl3, 500 MHz) 3.00 (apparent 
triplet, J=6.50 Hz, 2 H) 3.08 (apparent triplet, J=6.50 Hz, 2 H) 3.83 (s, 3 H) 6.76 - 6.84 
(m, 3 H) 7.23 - 7.30 (m, 1 H) 13C NMR (CDCl3, 125 MHz) δ ppm 28.59 (CH2) 38.26 
(CH2) 55.44 (CH3) 112.18 (CH) 115.82 (q, JC-F = 289.90 Hz, CF3) 114.43 (CH) 120.80 
(CH) 130.02 (CH) 141.12 (C) 160.15 (C) 190.89 (q, JC-C-F =33.90 Hz, C) 19F  NMR 
(CDCl3, 377 MHz) δ ppm -82.33 GC-MS (EI) 232 ([M]+, 78 %), 163 (14%), 135 (88%), 
121 (100%), 105 (15%), 91 (56%), 77 (21%), 69 (10%). HRMS (ESI+), calcd for 
C11H11F3O2  [M + H]+ 233.0789, found: 233.0798 
 
  1,1,1-trifluoro-4-(4-fluorophenyl)butan-2-one (107) (1.46 g, 
61%) was prepared according to the representative procedure B 
from N-methoxy-3-(4-fluorophenyl)-N-methylpropanamide (2.30 g, 10.89 mmol) (167). 
Vacuum distillation (b.p. 68-70 oC @ 3.0 mmHg) afforded the pure CF3 ketone as a 
clear colorless oil.  1H NMR (CDCl3, 400 MHz) δ ppm 2.97 (t, J=6.40 Hz, 2 H) 3.03 (t, 
J=6.10 Hz, 2 H) 6.99 (t, J=8.56 Hz, 2 H) 7.17 (dd, J=8.19, 5.50 Hz, 2 H) 13C NMR 
CF3
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(CDCl3, 100 MHz) δ ppm 27.78 (CH2) 38.37 (CH2) 115.77 (q, JC-F =291.20 Hz, CF3) 
115.78 (d, JC-C-F =21.27 Hz, CH) 130.05 (d, JC-C-C-F =7.34 Hz, CH) 135.18 (d, JC-C-C-C-F 
=2.93 Hz, C) 161.96 (d, JC-F =245.02 Hz, C-F) 190.78 (JC-C-F, J=35.90 Hz, C) 19F  NMR 
(CDCl3, 377 MHz) δ ppm -119.41 - -119.31 (m, 1 F) -82.35 (s, 3 F) GC-MS (EI) 220 
([M]+, 23%), 151 (28%), 123 (10%), 109 (100%), 96 (9%), 83 (10%), 69 (8%), 63 (3%). 
HRMS (ESI+), calcd for C10H8F4O  [M + H - H2O]+ 203.0484, found: 203.0489 
 
 1,1,1-trifluoro-4-( p-tolyl)butan-2-one 31  (108) (3.97 g, 78%) 
was prepared according to the representative procedure B from 
N-methoxy-3-( p-tolyl)-N-methylpropanamide  (6.70 g, 47.1 mmol) (168). Vacuum 
distillation (b.p. 68-71 oC @ 1.2 mmHg) afforded the pure CF3 ketone as a clear 
colorless oil.      1H NMR (CDCl3, 400 MHz) δ ppm 22.34 (s, 3 H) 2.97 (apparent triplet, 
J=6.80 Hz, 2 H) 3.04 (apparent triplet, J=6.60 Hz, 2H) 7.08 - 7.16 (m, 4 H) 13C NMR 
(CDCl3, 100 MHz) δ ppm 21.18 (CH3) 28.13 (CH2) 38.44 (CH2) 115.83 (q, JC-F =292.00 
Hz, CF3) 128.40 (CH) 129.64 (CH) 136.46 (C) 136.50 (C) 190.97 (q, JC-C-F =35.20 Hz, 
CF3) 19F  NMR (CDCl3, 377 MHz) δ ppm -82.24  GC-MS (EI) 216 ([M]+, 35%), 147 
(22%), 119 (9%), 105 (100%), 91 (16%), 77 (14%), 69 (7%), 65 (6%). 
 
 
 1,1,1-trifluoro-4-(4-methoxyphenyl)butan-2-one31 (109) 
(9.28 g, 73%) was prepared according to the representative 
procedure B from N-methoxy-3-(4-methoxyphenyl)-N-methylpropanamide  (12.27 g, 
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54.96 mmol) (169). Vacuum distillation (b.p. 68-71 oC @ 0.2 mmHg) afforded the pure 
CF3 ketone as a clear colorless oil. 1H NMR (CDCl3, 500 MHz) δ ppm 2.94 (apparent 
triplet, J=6.80 Hz, 2 H) 3.02 (apparent triplet, J=6.60 Hz, 2 H) 3.79 (s, 3 H) 6.85 (d, 
J=8.56 Hz, 2 H) 7.12 (d, J=8.56 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 27.73 
(CH2) 38.61 (CH2) 55.49 (CH3) 115.77 (q, JC-F =292.00 Hz, CF3) 114.36 (CH) 129.51 
(CH) 131.53 (C) 158.62 (C) 191.00 (q, JC-C-F =35.90 Hz, C) 19F  NMR (CDCl3, 377 MHz) 
δ ppm -82.34 δ ppm GC-MS (EI) 232 ([M]+, 19%), 121(100%), 91 (13%), 77 (10%), 69 
(4%), 65 (5%). 
 
 1,1,1-trifluoro-4-(furan-2-yl)butan-2-one (111) (1.01 g, 52%)was 
according to the representative procedure B from 3-(furan-2-yl)-N-
methoxy-N-methylpropanamide (1.86 g, 0.01015) (179) with the following modification: 
Flash chromatography (Gradient Hex to 8:2 Hex:EtOAc) afforded the pure CF3 ketone 
as a  clear light brown oil. 1H NMR (CDCl3) δ ppm 3.03 (apparent t, J=6.90 Hz, 2 H) 
3.09 (apparent t, J=6.30 Hz, 2 H) 6.05 (d, J=2.52 Hz, 11 H) 6.29 (t, J=2.50 Hz, 12 H) 
7.31 (d, J=1.26 Hz, 11 H) 13C NMR (CDCl3) δ ppm  21.17 (CH2) 35.11 (CH2) 106.17 
(CH) 110.58 (CH) 115.81 (q, JC-F =290.50 Hz, CF3) 141.83 (CH) 152.90 (C) 190.50 (q, 
JC-C-F =35.90 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -82.21 GC-MS (EI) 192 ([M]+, 
29%), 123 (24%),  95 (8%), 81 (100%), 69 (10%), 53 (21%), 39 (10%).  HRMS (ESI+), 
calcd for C8H7F3O2  [M+H]+193.0476, found: 193.0486 
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 2,2,2-trifluoro-1-(naphthalen-1-yl)ethanone 32  (112) (0.941 g, 84%) 
was prepared according to the representative procedure A from N-
methoxy-N-methylnaphthalene-1-carboxamide (1.076 g, 5 mmol) (149). 
Flash chromatography (8:2 hexanes/ CH2Cl2) produced the pure CF3 ketone as a brown 
solid.   1H NMR (CDCl3, 400 MHz) δ ppm 7.55 (t, J=7.83 Hz, 1 H) 7.60 (t, J=7.60 Hz, 1 
H) 7.70 (t, J=8.30 Hz, 1 H) 7.91 (d, J=8.31 Hz, 1 H) 8.13 (d, J=8.07 Hz, 1 H) 8.21 (d, 
J=7.58 Hz, 1 H) 8.87 (s, 1 H) 13C NMR (CDCl3, 100 MHz) δ ppm 116.94 (q, JC-F = 
293.40 Hz, CF3) 124.38 (CH) 125.44 (CH) 126.54 (C) 127.38 (CH) 129.25 (CH) 129.74 
(CH) 131.44 (C) 131.95 (q, JC-C-C-C-F = 3.67 Hz,) 134.21 (C) 136.45 (CH) 182.54 (q, JC-C-
F = 34.50 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -73.01 GC-MS (EI) 224 ([M]+, 31%), 
155 (87%), 127 (100%), 101 (7%), 77 (11%), 69 (3%), 63 (10%). 
 
 
 1-(5-bromothiophen-2-yl)-2,2,2-trifluoroethanone33 (113) (0.785 g, 
63%) was prepared according to the representative procedure A from 
5-bromo-N-methoxy-N-methylthiophene-2-carboxamide (1.251 g, 5 mmol) (171). Flash 
chromatography (100 % Hex) afforded the pure CF3 ketone as a yellow oil.   1H NMR 
(CDCl3, 400 MHz) δ ppm 7.21 (d, J=4.16 Hz, 1 H) 7.69 (m, 1 H) 13C NMR (CDCl3, 100 
MHz) δ ppm 116.42 (q, JC-F = 292.00 Hz, CF3) 128.21 (C) 132.69 (CH) 137.10 (q, JC-C-C-
C-F =2.90 Hz, CH) 138.00 (C) 172.76 (q, JC-F =36.70 Hz, C) 19F  NMR (CDCl3, 377 MHz) 
δ ppm -75.33 GC-MS (EI) 260 ([M]+1, 31%), 258 ([M]-1, 30%), 191 (100%), 189 (99%), 
163 (11%), 161 (11%), 119 (11%), 117 (11%), 82 (47%), 69 (14%), 57 (10%). 
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 2,2,	   2-trifluoro-1-(pyridin-4-yl)ethane-1,1-diol34 (114) (0.865 g, 80%) 
was prepared according to the representative procedure A from N-
methoxy-N-methylisonicotinamide (0.831 g, 5 mmol) (180) with the following 
modifications to the cleavage step: Prior to the addition of TBAF/H2O, the reaction 
mixture was cooled to 0 oC.  At this time 5 mL of deionized H2O was added to the flask 
followed by drop wise addition of 20 mL of a 0.25M solution of TBAF CAUTION: The 
first few drops induce a violent reaction and evolved gas therefore slow addition over 10 
minutes is recommended. The remained of the cleavage and subsequent workup was 
carried out as detailed in Procedure A. This afforded the pure CF3 ketone in its hydrated 
form as a tan solid.   1H NMR (Acetone-d6, 400 MHz) δ ppm 7.09 (br. s., 2 H) 7.66 (d, 
J=4.65 Hz, 2 H) 8.64 (d, J=4.65 Hz, 2 H) 13C NMR (Acetone-d6, 100 MHz) δ ppm 93.34 
(q, JC-C-F =32.30 Hz, C) 124.11 (q, JC-F =287.60 Hz, CF3) 123.00 (CH) 147.66 (C) 150.40 
(CH) 19F  NMR (Acetone-d6, 377 MHz) δ ppm -  84.13 GC-MS  (EI) 175 ([M]+, 38%), 106 
(95%), 78 (100%), 69 (12%), 59 (12%), 51 (52%), 50 (20%), 44 (28%). 
 
 1-(3,5-dimethoxyphenyl)-2,2,2-trifluoroethanone (115) (1.16 g, 
99%) was prepared according to the representative procedure A 
from N,3,5-trimethoxy-N-methylbenzamide (1.113 g, 5 mmol) (172) 
giving the pure CF3 ketone as a light brown oil. No further purification was required.   1H 
NMR (CDCl3, 400 MHz) δ ppm 3.82 (s, 6 H) 6.75 (s, 1 H) 7.15 (s, 2 H)  13C NMR (CDCl3, 
100 MHz) δ ppm 55.83 (CH3) 107.91 (CH) 108.16 (CH) 116.86 (q, JC-F 291.20 Hz, CF3) 
N
CF3
HO OH
CF3
O
MeO
OMe
114
 
115
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131.66 (C) 161.31 (C) 180.46 (q, JC-C-F =35.20 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ 
ppm -73.91 GC-MS (EI) 234 ([M]+, 69%), 165 (100%), 137 (35%), 122 (49%), 107 
(20%), 79 (11%), 77 (16%), 69 (11%), 63 (16%). HRMS (ESI+), calcd for C10H9F3O3  
[M+ H]+ 235.0582, found: 235.0582  
 
 1,1,1-trifluorononan-2-one 35  (116) (1.84 g, 59%) was 
prepared according to the representative procedure B from N-
methoxy-N-methyloctanamide (3.00 g, 16 mmol) (97). Vacuum distillation (b.p. 67-70 oC 
@ 12 mmHg) afforded the pure CF3 ketone as a pale yellow oil.   1H NMR (CDCl3, 400 
MHz) δ ppm 0.87 (t, J=6.60 Hz, 3 H) 1.22 - 1.33 (m, 8 H) 1.66 (quin, J=6.97 Hz, 2 H) 
2.69 (t, J=7.21 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 14.22 (CH3) 22.68 (CH2) 
22.83 (CH2) 29.00 (CH2) 29.15 (CH2) 31.85 (CH2) 36.62 (CH2) 115.92 (q, JC-F = 292.00 
Hz, CF3) 191.88 (q, JC-C-F = 33.70 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -82.51 GC-
MS (EI) 127 (92%), 109 (7%), 84 (17%), 69 (41%), 57 (100%), 55 (43%), 43 (49%), 41 
(50%), 39 (15%). 
 
 3-cyclohexyl-1,1,1-trifluoropropan-2-one35 (117) (1.82 g, 61%) was 
prepared according to the representative procedure B from 2-
cyclohexyl-N-methoxy-N-methylacetamide (3.000 g, 16 mmol) (173). Vacuum distillation 
(b.p. 55-57 oC @ 7 mmHg) afforded the pure CF3 ketone as a pale yellow oil.   1H NMR 
(CDCl3, 400 MHz) δ ppm 0.98 (apparent q, J=10.80 Hz, 2 H) 1.15 (apparent q, J=12.00 
Hz, 1 H) 1.29 (apparent q, J=12.00 Hz, 2 H) 1.61 - 1.76 (m, 5 H) 1.86-1.99 (m, 1 H) 2.56 
O
CF3
CF3
O
116
 
117
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(d, J=6.85 Hz, 2 H) 13C NMR (CDCl3, 100 MHz) δ ppm 26.16 (CH2) 26.26 (CH2) 33.13 
(CH2) 33.16 (CH) 44.04 (CH2) 115.82 (q, JC-C-F = 292.70 Hz, CF3) 191.32 (q, JC-F =34.50 
Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -82.51 GC-MS (EI) 194 ([M]+, .01%), 125 
(73%), 97 (72%), 82 (87%), 69 (24%), 67 (51%), 55 (100%), 41 (37%), 39 (20%). 
 
 1,1,1-trifluoro-4,8-dimethylnon-7-en-2-one36 (118) (0.538 g, 48%) was 
prepared according to the representative procedure A from N-methoxy-
N,3,7-trimethyloct-6-enamide  (1.067 g, 5 mmol) (178) 1H NMR (CDCl3, 
500 MHz) δ ppm0.96 (d, J=6.94 Hz, 3 H) 1.22 - 1.42 (m, 2 H) 1.60 (s, 3 H) 1.69 (d, 
J=1.26 Hz, 3 H) 1.91 - 2.07 (m, 2 H) 2.12 (sxt, J=6.30 Hz, 1 H) 2.48 - 2.58 (m, 1 H) 2.70 
(dd, J=17.97, 5.36 Hz, 1 H) 5.07 (t, J=7.40 Hz, 1 H)  13C NMR (CDCl3, 100 MHz) δ ppm 
17.81 (CH3) 19.68 (CH3) 25.61 (CH2) 25.88 (CH3) 28.29 (CH) 36.86 (CH2) 43.72 (CH2) 
115.83 (q, JC-F=291.00 Hz, CF3) 124.06 (CH) 132.24 (C) 191.43 (q, JC-C-F =34.50 Hz, C) 
19F  NMR (CDCl3, 377 MHz) δ ppm -82.59 GC-MS (EI) 222 ([M]+, 20%), 153 (7%), 109 
(26%), 95 (26%), 83 (12%), 69 (100%), 67 (12%), 55 (35%), 43 (7%), 41 (53%), 39 
(10%).  
 
 1-(5-bromofuran-2-yl)-2,2,2-trifluoroethanone 37  (119) (2.75 g, 
66%) was prepared according to the representative procedure B from 
5-bromo-N-methoxy-N-methylfuran-2-carboxamide (4.00 g, 17.09 mmol) (181). Vacuum 
distillation (b.p. 73-75 oC @ 8 mmHg) afforded the pure CF3 ketone as a bright yellow oil.   
1H NMR (CDCl3, 500 MHz) δ ppm 6.64 (d, J=3.78 Hz, 1 H) 7.41 - 7.45 (m, 1 H) 13C 
O
CF3
OBr
CF3
O
118
 
119
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NMR (CDCl3, 125 MHz) δ ppm 116.28 (q, JC-F = 289.10 Hz, 33 C) 115.75 (CH) 126.29 
(CH) 134.26 (C) 148.86 (C) 167.47 ((q, JC-C-F = 38.10 Hz, 4 C) 19F  NMR (CDCl3, 377 
MHz) δ ppm -76.54 GC-MS (EI) 245 ([M]+, 81Br  7%), 243([M]+, 79Br  7%), 175 (81Br  
97%), 173 (79Br  100%),147 (81Br 6%), 147 (79Br  6%) 119 (81Br 35%), 117 (79Br  36%) 
94 (8%) 69 (33%) 66 (19%) 38 (30%) 
 
 (E)-1,1,1-trifluoro-4-phenylbut-3-en-2-one38 (120) (.221 g, 22%) 
was prepared according to the representative procedure A from N-
methoxy-N-methylcinnamide (0.956 g, 5 mmol) (146) with the following modification: 
The cleavage was conducted at room temperature4 rather than heating at 50 oC. Flash 
chromatography (8:2 Hex/EtOAc) afforded the pure CF3 ketone as a yellow oil.   1H 
NMR (CDCl3, 400 MHz) δ ppm 7.03 (d, J=15.89 Hz, 1 H) 7.42 - 7.54 (m, 3 H) 7.65 (d, 
J=7.58 Hz, 2 H) 7.98 (d, J=15.89 Hz, 1 H) 13C NMR (CDCl3, 100 MHz) δ ppm  116.69 (q, 
JC-F = 291.20 Hz, CF3) 116.89 (CH) 129.51 (2 X CH) 132.60 (CH) 133.59 (C) 150.44 
(CH) 180.28 (q, JC-C-F = 35.20 Hz, C) 19F  NMR δ ppm (CDCl3, 377 MHz) -80.73 GC-MS 
(EI) 200 ([M]+, 50%), 131 (100%), 103 (85%), 77 (34%), 69 (6%), 51 (24%). 
 
 (E)-1,1,1-trifluoro-4-(4-methoxyphenyl)but-3-en-2-one 39 
(121) (0.535 g, 46%) was prepared according to the 
representative procedure A from (E)-N-methoxy-3-(4-methoxyphenyl)-N-
methylacrylamide (1.106 g, 5 mmol) (174) with the following modification: The cleavage 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 Heating leads to decreased yield of the desired α,β-unsaturated CF3 ketone and an 
increase in the undesired 1,4-addition product 
CF3
O
CF3
O
MeO
120
 
121
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was conducted at room temperature4 rather than heating at 50 oC. Flash 
chromatography (8:2 Hex/EtOAc) afforded pure CF3 ketone as a yellow solid.   1H NMR 
(CDCl3, 400 MHz) δ ppm 3.87 (s, 3 H) 6.88 (d, J=15.89 Hz, 1 H) 6.95 (d, J=8.80 Hz, 2 
H) 7.60 (d, J=8.07 Hz, 2 H) 7.93 (d, J=15.89 Hz, 1 H) 13C NMR (CDCl3, 100 MHz) δ 
ppm 55.77 (CH3) 114.28 (CH) 115.02 (CH) 116.84 (q, JC-F = 291.02 Hz, CF3) 126.43 (C) 
131.66 (CH) 150.23 (CH) 163.48 (C) 180.15 (q, JC-C-F = 32.30 Hz, C) 19F  NMR (CDCl3, 
377 MHz) δ ppm -80.58 GC-MS (EI) 230 ([M]+, 37%), 161 (100%), 133 (34%), 118 
(16%), 89 (16%), 69 (4%), 63 (10%). 
 
(E)-1,1,1-trifluoro-4-(4-fluorophenyl)but-3-en-2-one 40  (122) 
(0.450 g, 41%) was prepared according to the representative 
procedure A from (E)-3-(4-fluorophenyl)-N-methoxy-N-methylacrylamide (1.046 g, 5 
mmol) (175) with the following modification: The cleavage was conducted at room 
temperature rather than heating at 50 oC.  Flash chromatography (9:1 Hex/EtOAc) 
afforded the pure CF3 ketone as a yellow solid.   1H NMR (CDCl3, 400 MHz) δ ppm  6.95 
(d, J=15.89 Hz, 1 H) 7.15 (t, J=8.44 Hz, 2 H) 7.66 (dd, J=8.56, 5.62 Hz, 2 H) 7.93 (d, 
J=15.89 Hz, 1 H) 13C NMR (CDCl3, 125 MHz) δ ppm 116.65 (q, JC-F=289.80 Hz, CF3) 
116.62 (CH) 116.84 (d, JC-C-F =22.01 Hz, CH) 129.96 (d, JC-C-C-C-F =2.94 Hz, C) 131.68 
(d, JC-C-C-F=8.80 Hz, CH) 148.99 (CH) 165.40 (d, J=255.29 Hz, C-F) 180.14 (q, JC-C-
F=35.20 Hz, C)  19F  NMR (CDCl3, 377 MHz) δ ppm -80.70 (s, 3 F) -108.71 -  -108.59 (m, 
1 F) GC-MS (EI) 218 ([M]+, 30%), 149 (100%), 121 (51%), 101 (55%), 95 (10%), 75 
(18%), 69 (8%). 
CF3
O
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 (E)-	   1,1,1-trifluoro-4-(furan-2-yl)but-3-en-2-one40 (123) (0.482 g, 
51%) was prepared according to the representative procedure A 
from (E)-3-(furan-2-yl)-N-methoxy-N-methylprop-2-enamide (0.906 g, 5 mmol) (176) 
with the following modification: The cleavage was conducted at room temperature4 
rather than heating at 50 oC. Flash chromatography (Gradient 9:1 to 8:2 Hex:EtOAc) 
afforded the pure CF3 ketone as a brown oil.   1H NMR (CDCl3, 400 MHz) δ ppm 6.57 
(dd, J=3.42, 1.71 Hz, 1 H) 6.85 - 6.93 (m, 2 H) 7.60 (d, J=0.49 Hz, 1 H) 7.68 (d, J=15.65 
Hz, 1 H) 13C NMR (CDCl3, 100 MHz) δ ppm 116.72 (q, JC-F =290.50 Hz, CF3) 113.71 
(CH) 114.15 (CH) 120.21 (CH) 135.02 (CH) 147.26 (CH) 150.84 (C) 180.13 (JC-C-F 
=35.20 Hz, C) 19F  NMR (CDCl3, 377 MHz) δ ppm -80.69 GC-MS (EI) 190 ([M]+, 36%),  
121 (100%), 93 (7%), 69 (9%), 65 (56%), 63 (12%), 39 (20%). 
 
A Weinreb Amide Approach to Difluoromethyl Ketones: 
 
 
 
1,1-Difluoro-4-phenyl-3-buten-2-one41 (147) 
To a round bottom flask equipped with a stir bar was added N-methoxy-N-
methylcinnamide (0.192 g, 1.0 mmol, 1.0 equiv.). THF (1.4 mL) was added, the flask 
O
CF3
O
Me3Si
F
F
2 equiv. KOtBu, 
THF
>99% conversion
N
O
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was sealed with a septum and the contents were cooled to 0 oC. Freshly prepared 
(difluoromethyl)trimethylsilane42 (0.1863 g, 1.5 mmol, 1.5 equiv.) was then added drop 
wise to the reaction mixture via a syringe. Lastly, KOtBu  (0.224 g, 2.0 mmol, 2.0 equiv.) 
was added in one portion to the reaction mixture. The contents were allowed to stir 
overnight. Progress of the reaction was monitored through dilution of an aliquot with 
diethyl ether (2 mL). The organics were washed with H2O (2 mL), dried with sodium 
sulfate, and removed in vacuo. 1H NMR suggested quantitative conversion to (E)-1,1-
difluoro-4-phenylbut-3-en-2-one. 1H NMR (CDCl3, 400 MHz) δ 5.92 (t, J = 54.0 Hz, 1 H), 
7.04 (d, J  = 16.1 Hz, 1H), 7.33-7.63 (m, 5 H), 7.89 (d, J = 16.1, 1H). 
General Procedure for Attempts Towards 1,1-difluroalkenes: 
n-BuLi and t-BuLi Attempts without Additives:	   
 	  	  
	  
Freshly distilled THF (1 mL) was added to a sealed flame-dried flask under nitrogen. 
The contents were cooled to -78 oC and (difluoromethyl)trimethylsilane42 (0.155 g, 1.25 
mmol, 5.0 equiv.) was added to the flask. Then butyl lithium (1.0 mmol, 4.0 equiv.) was 
added drop wise to the reaction mixture. Contents were stirred for 5 minutes. 
Benzo[1,3]dioxole-5-carbaldehyde (0.0375g, 0.25 mmol, 1.0 equiv.) was diluted in THF 
(0.5 mL) and was added drop wise to the reaction. Progress of the reaction was 
assayed after 30 minutes by dilution of an aliquot with diethyl ether (2 mL). The organics 
Si F
F H R-Li
 -78 oC, 
5 min
Si F
F Li O
O
H
O
O
O
H
F F
x
-78 oC, 30 min
140
 
154 
158
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were washed with a solution of NH4Cl (2 mL), dried with sodium sulfate, and removed in 
vacuo. 1H NMR suggested butyl addition into the aldehyde. 
	  
n-BuLi and Attempts with TMEDA: 
 	  	  	  	  
Freshly distilled THF (2 mL) was added to a sealed flame-dried flask under nitrogen. 
The contents were cooled to -30 oC and (difluoromethyl)trimethylsilane42 (0.228 g, 2.0 
mmol, 1.0 equiv.) was added to the flask, followed by TMEDA (0.328 mL, 2.2 mmol, 1.1 
equiv.). Then n-butyl lithium (2.0 mmol, 1.0 equiv.) was added drop wise to the reaction 
mixture. Contents were stirred for 90 minutes, and then cooled to -78 oC. 
Benzo[1,3]dioxole-5-carbaldehyde (0.3302g, 2.2 mmol, 1.1 equiv.) was diluted in THF 
(4.0 mL) and was added drop wise to the reaction. Progress of the reaction was 
assayed after 30 minutes through a quench with a solution of NH4Cl (6mL), and 
extraction with diethyl ether (6 mL). Organics were dried with sodium sulfate, and 
removed in vacuo. 1H NMR suggested no reaction. 
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Appendix 1 (A.1): Exploring New Methods for Aryl Nitriles: 
 
The Evolution of Cyanation Reactions: 
	   Cyanation of aryl halides has been a significant area of study since the early 
1900s.1 Aryl nitriles are found in many natural products, used in dyes, herbicides, 
agrochemicals, and pharmaceuticals.2 These compounds are also extremely useful 
intermediates for organic synthesis, mainly the formation of heterocycles.2 Many 
modifications have been made to the original synthetic methodologies due to toxic 
cyanide salts and harsh conditions. A major goal of the Leadbeater group is to transform 
this method to a quicker, and greener process through risk-free reagents and 
microwave technology.3 
 Conversion of aryl halides to 
nitriles was first introduced via the 
Rosenmund-von Braun reaction in the 
early 1900s. In 1919 Rosenmund had 
developed a protocol for the 
production of aryl esters from bromide 
precursors (Compounds A1 to A2).4 
The reaction was completed in water with potassium cyanide, potassium hydroxide, and 
copper (I) cyanide. Although it was not isolated, Rosenmund suggested the reaction 
proceeded through a nitrile intermediate.4 In 1931, Von Braun developed the cyanation 
Scheme A.1: Rosenmund-Von Braun Reaction 4,6 
e 
R
Br KCN, KOH, CuCN
180-200 oC, H2O
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O
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Br
CuCN
CN
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of 4-bromofluoranthene (A3) to nitrile A4. The reaction was conducted at 260 oC for 6 
hours, solvent-free with copper (I) cyanide.5 This synthetic breakthrough was deemed 
the Rosenmund-Von Braun reaction.4,5 
 As the use for aryl nitriles became popularized, so did the demand for a safer, 
greener method. New protocols for transition metal-catalyzed reactions were developed. 
Some early transformations involved the use of palladium catalysts with an MCN source 
to eradicate the use of stoichiometric CuCN. Tagaki et al. reported a synthesis of aryl 
nitriles from haloarenes utilizing Pd (II) salts, including Pd(CN)2 and Pd(OAc)2.  The 
catalysts were combined with KCN in DMF to produce high conversions of the aryl 
nitriles.6 Later, Pd(PPh3)4 was also studied as a suitable catalyst for these reactions.7,8	  	  
	   The use of palladium catalysts 
with cyanide salts resulted in 
disadvantages of poisoned or 
deactivated catalysts, limited 
susbtrate scope, and low reaction yields. These drawbacks were circumvented with the 
emergence of K4Fe(CN)6 as a cyanide source.9	  Potassium hexacyanoferrate is a safe 
and mild oxygen-transfer agent commercially used in red wines to improve color through 
the precipitation of iron ions.10 The use of this salt for cyanation reactions greatly 
reduces the toxic effects of previous methodologies, and can be used without any 
precaution. Schareina, Zapf, and Beller first employed this cyanide source in 2004 using 
aryl bromides and chlorides with palladium catalysts (Scheme A.2).9	  ,11 
R
X K4Fe(CN)6, Pd/dppf
Na2CO3
120-140 oC R
CN
X= Cl, Br
Scheme A.2: First Use of K4Fe(CN)6 for Cyanation 
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 New technologies to perform 
cyanation reactions have evolved with the 
emergence of greener reagents. 
Microwave reactors have been used as a tool for the quick conversion of aryl halides to 
the corresponding nitriles. Deblase and Leadbeater had optimized the potassium 
hexacyanoferrate reactions with microwave irradiation.12 Aryl iodides were converted in 
water using K4Fe(CN)6, CuI as catalyst, and TEG as a phase transfer agent. The 
reactions were held at 175 oC for 30 minutes to yield up to 79% of the cyanides. Aryl 
bromides were not tolerant of this methodology.12 
Deblase and Leadbeater made a significant discovery with further studies of 
K4Fe(CN)6 and copper catalysts. When catalyst CuO was used, a change of color from 
black to purple occurred to the reaction mixture.13 This color change was found to be a 
resultant of Cu2Fe(CN)6 formed. Copper hexacyanoferrate was synthesized and 
screened. This acts as both a cyanide source and catalyst. Only 30 mol% of 
Cu2Fe(CN)6 is needed for the reaction. The conversions of aryl iodides were reported 
with water and a phase transfer agent 
(Scheme A.4). Aryl bromides were 
not reported for this methodology.13  
 
 
 
R
I K4Fe(CN)6, CuI
H2O, glycol
MW, 175 oC 30 min R
CN
Scheme A.3: Microwave Assisted Cyanation 
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Scheme A.4: Microwave Assisted Cyanation with Cu2Fe(CN)6 
e 
A6
 
A7
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Our Work Towards the Cyanation of Aryl Bromides: 
 We had sought to develop a method for the production of aryl nitriles from their 
corresponding bromides. Table A.1 summarizes the attempted reactions with substrate 
A8. Since aryl bromides were not reported as starting materials in Deblaseʼs and 
Leadbeater's cyanation attempts in water, we began with altering solvent. Acetonitrile 
and ionic liquid [BMIM]+ I- were employed for transformation of A8 to A9 (Table A.1, 
entries 1-3). Heating the reaction to 200 oC for 30 minutes with a catalytic amount of 
Cu2Fe(CN)6 (30 mol%) resulted in 23% conversion to A9 (Table A.1, entry 1). 
Employing a stoichiometric amount of Cu2Fe(CN)6 resulted in a greater conversion of 
61% (Table A.1, entry 2). The reaction time was lengthened to 60 minutes, and to our 
delight a 93% conversion was observed (Table A.1, entry 3). A water wash of the 
reaction mixture followed by an ethyl acetate extraction resulted in crude product. The 
recovery was measured via 1H NMR with internal standard 1,2,4,5-tetramethylbenzene. 
Unfortunately, only 39% of A9 was recovered (Table A.1, entry 3). We hypothesized 
that the product was not fully extracted from the ionic liquid, compromising yield. The 
reaction was then completed in the absence of [BMIM]+ I-. Both a stoichiometric and 
catalytic amount of Cu2Fe(CN)6 were used, each resulting in about 80% conversion 
(Table A.1, entries 4-5). The highest yield observed was 49% (Table A.1, entry 5). 
When attempting the reaction with K4Fe(CN)6 and Cu2O only starting material was 
observed. 
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We further conducted trials to understand why the conversion of the reaction was 
high but the recovery was low. One idea was the temperature was too high and 
decomposing the reaction contents. It was reduced from 200 oC to150 oC. However, 
only 2% conversion of A9 was observed. To further disprove our theory we combined a 
known amount of 4-bromobenzonitrile, 4-bromoanisole, internal standard, and 
acetonitrile in a microwave vessel. The contents were heated to 200 oC for 1 hour and 
then measured via 1H NMR. Quantitative amounts of each were recovered. This 
suggests that the starting material and product did not decompose at high temperatures.  
 We believe the contents are lost upon work-up. Subsequent to the end of the 
reaction the contents were diluted in ethyl acetate, and washed with water. The water is 
then extracted multiple times with ethyl acetate. A viscous polymeric-like material was 
observed, which also created emulsions upon work up. The highest recovery of 49% 
occurred when the reaction mixture was stirred in ethyl acetate over the course of 1-2 
hours. This method was not feasible to continue due to the low reaction yields. 
Br Cu2Fe(CN)6
MW, solvent
CN
MeO MeO
Table A.1: Cyanation Attempts 
e 
Entry Cu2Fe(CN)6 Equiv. Solvent Time Temp. Conv. Yield 
1 0.3 MeCN/[BMIM]+ I- 30 min 200 oC 23% N/A 
2 1.0 MeCN/[BMIM]+ I- 30 min 200 oC 61% N/A 
3 1.0 MeCN/[BMIM]+ I- 1 h 200 oC 93% 39% 
4 1.0 MeCN 1 h 200 oC 83% 36% 
5 0.3  MeCN 1 h 200 oC 81% 49% !
A9
 
A8
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Representative Procedure for Cyanation: 
 
 
To a 10-mL microwave vessel equipped with a stir bar was added 4-bromoanisole 
(0.122 g, 1.0 mmol, 1 equiv.), acetonitrile (1 mL) and Cu2Fe(CN)6 ( 0.3-1.0 mmol, 0.3-
1.0 equiv.). The vessel was sealed and placed in the cavity of a CEM Discover 
microwave. The temperature was ramped to 200 oC and stirred for 1 h holding 
temperature. Once cooled, the contents were diluted in EtOAc (10 mL) and washed with 
water (5 mL). The aqueous layer was extracted with EtOAc (3 x 10mL). Organics were 
collected, dried with sodium sulfate, and filtered. Internal standard 1,2,4,5-
tetramethylbenzene (0.0671g, 0.5 mmol, 0.5 equiv.) was added and the solvent was 
removed in vacuo. Conversion was measured by 1H NMR. 
 
 
 
 
 
 
 
Br Cu2Fe(CN)6
MW, solvent
CN
MeO MeO A9
 
A8
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Appendix 2 (A.2): Utilizing Flow Technology for the Decarboxylative Heck 
Coupling: 
 
Microwave and Continuous Flow Technologies: 
A significant theme of the New Synthetic Methods Group is the utilization of new 
technologies for quicker, cleaner, and greener chemistries. Microwave and continuous 
flow reactors are the tools exploited for these goals. Many literature protocols involve 
small-scale reactions to explore the scope and limitation of the methodology. Our goal is 
to improve upon the reaction times through microwave heating and transition the 
method for scale-up in the continuous flow reactor.  
One of the common 
misconceptions of microwave heating 
is it employs a “microwave effect” to 
break bonds and therefore force 
reactivity. 14  However, this is not the 
case. Microwave reactors are tools for 
controlled super heating that only 
agitate bonds. Round bottom flasks 
that are placed upon a heat source are 
warmed through contact. Contrastingly, 
microwave sources allow for homogenous heating throughout the reaction mixture, 
resulting in a steadied and controlled warming process.14 A pressure locking system is 
Figure A.1 CEM Discover Microwave 
e 
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one of the capabilities of the CEM Discover microwave unit the lab is equipped with. 
The reaction vessels are built to withstand pressures of up to 300 psi. This is 
advantageous for a quicker reaction time as temperatures much higher than the boiling 
point of the solvent are tolerated. The greater temperatures, and consequently higher 
pressures are accountable for the shorter reaction times.  
 Once a method is 
transitioned from batch 
to microwave protocols, 
attention can then be 
focused on reaction 
scale-up. Although larger 
microwaves may be 
employed, another useful 
technology is the 
continuous flow reactor. 
The concept behind the 
flow reactor is a series of small-scale reactions allowing for safer and controlled 
chemistry. This is possible by small reaction coils that are wrapped around a heat 
source. The reactor employs conventional heating, however, the small diameter of the 
long coil allows for a larger contact surface area by the heat source than a round bottom 
flask. Reactions that may be dangerous and explosive especially upon scale-up may 
safely be run in a flow reactor due to a series of continuously flowing mini-reactions. 
Figure A.2 Vapourtec Flow System 
e 
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One system that the lab is equipped with is the Vapourtec flow system, which has low 
temperature, high temperature, and gas loading capabilities.  
The Decarboxylative Heck Reaction: 
 The Leadbeater lab is continuously searching for conventional reaction methods 
that would benefit from microwave and flow technologies. One reaction targeted was the 
decarboxylative Heck coupling. The Myersʼs group first reported this chemistry with the 
coupling of various benzoic acids (A10) and substituted alkenes (A11) in the presence 
of a palladium catalyst and a silver salt to yield compounds A12 (Scheme A.5).15 
Recently, many variations of this reaction have been studied.16 It was thought that the 
silver salt is key for decarboxylation.17 However, Su et. al recently found that dioxygen 
may be replaced as the terminal oxidant allowing for a greener process.18 Electron rich 
aromatic carboxylic 
acids were coupled to 
methyl acrylate with 
Pd(OAc)2, and O2, in a 
5% DMSO-DMF 
solution.	    Reactions 
were run in 10 hours 
at 120 oC with 23-
91% yields.  
  
OH
OR1
R2
 Pd(O2CCF3)2, Ag2CO3
20:1 DMF/DMSOR4
R3
R1
R2
R3
R4
18 examples, 42-99%
Scheme A.5: Decarboxylative Heck Reaction 
A10
 
A11
 
A12
 
OH
OR1
R2
 Pd(OAc)2, O2
20:1 DMF/DMSOR4
R3
R1
R2
R3
R4
15 examples, 23-94%
Scheme A.6: Decarboxylative Heck with O2 Oxidant 
e 
A10
 
A11
 
A12
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Our CEM discover and Vapourtec systems are both equipped with gas loading 
capabilities. Therefore, we embarked on transitioning the reaction from batch protocols 
to microwave and flow methods. We believed we could reduce the 10 h reaction time. 
Substrate A13 was chosen due to low cost and reported high reaction yield (Table 
A.2).18 Reaction yields were determined by integration of the internal standard 1,2,4,5-
tetramethylbenzene by 1H NMR. Initial trials were screened on a 0.2 mmol scale with 10 
mol% Pd(OAc)2, and 2 equivalents of methyl acrylate (A14). Su reported that higher 
yields were accomplished with a greater pressure of oxygen.18 Therefore, 200 psi of 
oxygen was employed as a contrast to 1 atm (~ 15 psi) used by the Su group. The 
reaction was heated to 150 oC for 1 h, resulting in a 74% yield of A15  (Table A.2, entry 
1). To our delight a 90% yield was observed when reducing catalyst loading to 5 mol% 
(Table A.2, entry 2). Lowering the temperature to 140 oC did not effect the yield (Table 
A.2, entry 3). An optimized reaction time of 30 minutes was observed (Table A.2, entry 
4). Reducing the time to 15 minutes or reducing catalyst loading (1 mol%) resulted in 
sub-optimal yields (Table A.2, entries 5-6). The use of O2 was essential as no 
conversion was reported when dioxygen was not employed (Table A.2, entry 7). Pure 
product was isolated in a 67% yield when optimized conditions were used (Table A.2, 
entry 4).	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With microwave conditions optimized we next sought to transition the method to 
a continuous flow protocol. We began mimicking the reaction at 140 oC with a 
resonance time of 30 min in 1 coil with a flow rate of 0.5 mL/min. A pressure of 250 psi 
of oxygen was needed in order to maintain homogeneous gas bubbles in the reaction 
coil. Only partial conversion was observed (Table A.3, entry 1). Table A.3 summarizes 
the reaction optimization. We next attempted increasing the resonance time to 1 hour by 
slowing the flow rate to 0.25 mL/min. A 70% yield was determined via internal standard 
(Table A.3, entry 2).  A second coil was added to increase the resonance time to 2 h. 
Product A15 was collected and passed through a pad of silica gel. Pure product was 
isolated in an 86% yield (Table A.3, entry 3). Other alkenes such as acrylonitrile were 
employed however decomposition was observed. When 2,4,5-trimethoxybenzoic acid 
was used as starting material with methyl acrylate only 70% conversion to the 
OMe
OHO
MeO
O
OMe
 Pd(OAc)2, O2
20:1 DMF/DMSO
OMe
OMe
OMe
O
Table A.2.: Microwave Optimization 
e 
Entry Pd(OAc)2 O2 Temperature Time Yield 
1 10 mol% 200 psi 150 oC 1.0 h 74% 
2 5 mol% 200 psi 150 oC 1.0 h 90% 
3 5 mol% 200 psi 140 oC 1.0 h 90% 
4 5 mol% 200 psi 140 oC 0.5 h 90%(67) 
5 5 mol% 200 psi 140 oC 15 min 63% 
6 1 mol% 200 psi 140 oC 0.5 h 40% 
7 5 mol% 0 psi 140 oC 0.5 h 0% !
A13
 
A14
 
A15
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corresponding product was observed. Therefore more optimization is needed for a 
broader substrate scope.  
 
Microwave Procedure for Decarboxylative Heck Coupling:	  	  
	  	  
(E)-methyl 3-(2,6-dimethoxyphenyl)prop-2-enoate:  
 
 
2,6-dimethoxybenzoic acid (0.0364g. 0.2 mmol, 1.0 equiv.) was weighed out and added 
to a microwave vessel equipped with a stir bar. Methyl acrylate (36 μL, 0.4 mmol, 2.0 
equiv.) was added to the vessel, which was then and purged with nitrogen. Dry DMF 
(2mL) was added via a syringe followed by 0.1 mL of a stock solution of 5% Pd(OAc)2 
(.01 mmol)  in DMSO. The reaction vessel was uncapped and the gas loading 
OMe
OHO
MeO
O
OMe
 Pd(OAc)2, O2
20:1 DMF/DMSO
OMe
OMe
OMe
O
Entry Pd(OAc)2 O2 Temperature Rate/Coils Time Result 
1 5 mol% 250 psi 140 
oC 0.5 mL/min 1 0.5 h partial Conv. 
2 5 mol% 250 psi 140 
oC 0.25 mL/min 1 1.0 h 70% yield 
3 5 mol% 250 psi 140 
oC 0.25 mL/min 2 2.0 h 86% yield !
A13
 
A14
 
A15
 
OMe
OHO
MeO
O
OMe
 Pd(OAc)2, O2
20:1 DMF/DMSO
MW, 140 oC, 30 min
67% yield
OMe
OMe
OMe
O
A13
 
A14
 
A15
 
Table A.3: Flow Optimization 
e 
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apparatus introduced 200 psi of dioxygen. It was heated to 140 0 C and held for 30 
minutes. Once cooled the contents were diluted in diethyl ether (10 mL), filtered through 
a small layer of silica gel, and extracted with diethyl ether (4 x 10 mL). The organics 
were transferred into a separatory funnel, and washed with a brine solution (2 x 20 mL). 
The organic layer was dried with sodium sulfate, and evaporated to dryness resulting in 
pure product (0.29 g, 67%). 1H NMR (CDCl3, 400 MHz) δ ppm 3.79 (s, 3H), 3.87 (s, 6H), 
6.55 (d, J = 8.37 Hz, 2 H), 6.88 (d, J = 16.26 Hz), 7.26 (t, J = 8.37 Hz), 8.13 (d, J = 
16.26 Hz) 
Continuous Flow Procedure for Decarboxylative Heck Coupling:	  	  	  
 
 
(E)-methyl 3-(2,6-dimethoxyphenyl)prop-2-enoate:  
2,6-dimethoxybenzoic acid (0.9109g. 5.0 mmol, 1.0 equiv.) was weighed out and added 
an Erlenmeyer flask and dissolved in dry DMF (50 mL). Methyl acrylate (0.900 mL, 10.0 
mmol, 2.0 equiv.) was added to the flask followed by 2.5 mL of a stock solution of 5% 
Pd(OAc)2 (.01 mmol)  in DMSO. The Vapourtec flow apparatus was primed, flushed, 
with DMF, introduced to a continuous flow of 250 psi O2, and heated to 140 OC. The 
reaction mixture was passed through 2 coils at a flow rate of 0.25 mL/min, and collected.  
Once cooled the contents were diluted in ether (100 mL), filtered through a small layer 
of silica gel, and extracted with diethyl ether (3 x 50 mL). The organics were transferred 
OMe
OHO
MeO
O
OMe
 Pd(OAc)2, O2
20:1 DMF/DMSO
Flow, .25mL/min,140 oC
86% yield
OMe
OMe
OMe
O
A13
 
A14
 
A15
 
	   122 
into a separatory funnel, and washed with a brine solution (3 x 50 mL). The organic 
layer was dried with sodium sulfate, and evaporated to dryness resulting in pure product 
( 0.957 g, 86%). 1H NMR (CDCl3, 400 MHz) δ ppm 3.79 (s, 3H), 3.87 (s, 6H), 6.55 (d, J 
= 8.37 Hz, 2 H), 6.88 (d, J = 16.26 Hz), 7.26 (t, J = 8.37 Hz), 8.13 (d, J = 16.26 Hz). 
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